University of Pennsylvania

ScholarlyCommons
Publicly Accessible Penn Dissertations
Fall 2011

Patterns of Weight Change in infants With Congenital Heart
Disease Following Neonatal Surgery: Potential Predictors of
Growth Failure
Sharon Y. Irving
University of Pennsylvania, ysha@nursing.upenn.edu

Follow this and additional works at: https://repository.upenn.edu/edissertations
Part of the Critical Care Nursing Commons, Dietetics and Clinical Nutrition Commons, and the
Pediatric Nursing Commons

Recommended Citation
Irving, Sharon Y., "Patterns of Weight Change in infants With Congenital Heart Disease Following Neonatal
Surgery: Potential Predictors of Growth Failure" (2011). Publicly Accessible Penn Dissertations. 443.
https://repository.upenn.edu/edissertations/443

This paper is posted at ScholarlyCommons. https://repository.upenn.edu/edissertations/443
For more information, please contact repository@pobox.upenn.edu.

Patterns of Weight Change in infants With Congenital Heart Disease Following
Neonatal Surgery: Potential Predictors of Growth Failure
Abstract
Abstract
Patterns of Weight Change in Infants with Congenital Heart Disease Following Neonatal Surgery:
Potential predictors of growth failure
Sharon Y Irving
DISSERTATION SUPERVISOR: BARBARA MEDOFF-COOPER, RN, PhD
Congenital heart disease (CHD) is reported to have an incidence of 9 to 14 per 1000 live births with a
prevalence estimated between 650,000 and 1.3 million persons in the United States (US). It is a structural
malformation(s) of one or more heart chamber(s) and/or deformity of one or more of the major
intrathoracic blood vessel(s) and the ensuing malady occurring during embryonic development. Up to
one-third of infants with CHD, require surgical intervention. Improved surgical technique over the last
several decades has seen an increased survival of neonates with CHD. Concomitantly there has been an
emergence of co-morbidities. Growth failure is a common co-morbidity following neonatal surgery for
CHD. More than 30% of these infants fall below the third percentile for weight early in their lives.
Postsurgical physiology, disease severity, feeding dysfunction, and a hypermetabolic state may all
contribute to growth failure, which has been associated with deficits in cognitive development, intellectual
ability and neurodevelopment, effecting maturation and school performance. Early recognition and
intervention of growth failure can improve health outcomes. The objective of this work is to identify
patterns of growth and growth failure in infants with CHD and explore potential predictors that may be
modifiable to mitigate growth failure and prevent the associated untoward consequences.

Degree Type
Dissertation

Degree Name
Doctor of Philosophy (PhD)

Graduate Group
Nursing

First Advisor
Barbara Medoff-Cooper, RN, PhD

Second Advisor
Martha A.Q. Curley, RN, PhD

Third Advisor
Virginia A. Stallings, MD

Keywords
growth failure, growth, energy expenditure, congenital heart disease, growth velocity

Subject Categories
Critical Care Nursing | Dietetics and Clinical Nutrition | Pediatric Nursing

This dissertation is available at ScholarlyCommons: https://repository.upenn.edu/edissertations/443

PATTERNS OF WEIGHT CHANGE IN INFANTS WITH CONGENITAL HEART
DISEASE FOLLOWING NEONATAL SURGERY: POTENTIAL PREDICTORS OF
GROWTH FAILURE
SHARON Y IRVING, CRNP
A DISSERTATION
In
Nursing
Presented to the Faculties of the University of Pennsylvania
In
Partial Fulfillment of the Requirements for the
Degree of Doctor of Philosophy
2011
Dissertation Supervisor: ___________________________________
Barbara Medoff-Cooper, RN, PhD, FAAN
Ruth M. Colket Professor of Pediatric Nursing

Graduate Group Chairperson: _______________________________
Marilyn S. Sommers, RN, PhD, FAAN
Lillian S. Brunner Professor of Medical-Surgical Nursing

Dissertation Committee:
Martha Curley, RN, PhD
Professor of Nursing
Charlene Compher, RD, PhD
Associate Professor of Nutrition Science
Virginia A Stallings, MD
Professor of Pediatrics

PATTERNS OF WEIGHT CHANGE IN INFANTS WITH CONGENITAL HEART
DISEASE FOLLOWING NEONATAL SURGERY: POTENTIAL PREDICTORS OF
GROWTH FAILURE
COPYRIGHT
2011
Sharon Y Irving

DEDICATION
To my parents:
You lived by the mantra “It takes a village”, and raised me in that way. Thank
you for placing me in the “right village” and always believing and supporting
even when you did not agree. I love you both. Mom, I wish you could see me
now.
To my close and my extended family:
You believed when it was unbelievable. Thank You.
To my very first nursing preceptors: Brenda, Rose and Miss Mary and Mrs. J:
Thank you for the tireless hours of teaching, repeating, answering questions,
and showing me how. You gave me the space to learn from you – look at what I
have learned.
To my many mentors along the way:
Each of you has helped me walk this journey. Thank You.

“I would like to be a scholar in whatever I do, a scholar is never finished, he is always
seeking and I am always seeking”.

Ahmad Jamal
iii

ACKNOWLEDGEMENTS
First always in my life is God.
To my family:
There are no words that can ever thank you enough for all the love and the
support and more love. Through the smiles and the tears, thank you, thank you, and
thank you. I pray I make you proud.
To my “Cultural Heritage” sistahs:
Danica, Margo, Bridgette – thank you for ‘Paying it Forward’. I learned from
your learning, your teaching and just by being in your presence. Thank you for
welcoming me with open arms, big hearts and lots of love. Each of you are a part of the
fabric that I am.
To my committee:
Thank you Barbara, Martha, Charlene and Ginanne. Each of you have inspired,
you taught, you mentored, you pushed, you pulled and in the end – you nurtured.

iv

ABSTRACT
PATTERNS OF WEIGHT CHANGE IN INFANTS WITH CONGENITAL HEART
DISEASE FOLLOWING NEONATAL SURGERY: POTENTIAL PREDICTORS OF
GROWTH FAILURE
SHARON Y IRVING
DISSERTATION SUPERVISOR: BARBARA MEDOFF-COOPER, RN, PhD
Congenital heart disease (CHD) is reported to have an incidence of 9 to 14 per
1000 live births with a prevalence estimated between 650,000 and 1.3 million persons
in the United States (US). It is a structural malformation(s) of one or more heart
chamber(s) and/or deformity of one or more of the major intrathoracic blood vessel(s)
and the ensuing malady occurring during embryonic development. Up to one-third of
infants with CHD, require surgical intervention. Improved surgical technique over the
last several decades has seen an increased survival of neonates with CHD.
Concomitantly there has been an emergence of co-morbidities. Growth failure is a
common co-morbidity following neonatal surgery for CHD. More than 30% of these
infants fall below the third percentile for weight early in their lives. Postsurgical
physiology, disease severity, feeding dysfunction, and a hypermetabolic state may all
contribute to growth failure, which has been associated with deficits in cognitive
development, intellectual ability and neurodevelopment, effecting maturation and
school performance. Early recognition and intervention of growth failure can improve
health outcomes. The objective of this work is to identify patterns of growth and growth
failure in infants with CHD and explore potential predictors that may be modifiable to
mitigate growth failure and prevent the associated untoward consequences.
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INTRODUCTION
Congenital heart disease (CHD) is defined as the structural malformation(s) of
one or more heart chambers and/or deformities of the major intrathoracic blood vessels
and the ensuing malady that occurs during embryonic development. The incidence of
CHD reported to be 9 to 14 per 1,000 live births,1-3 has a prevalence estimated
between 650,000 and 1.3 million persons in the United States (US).1,4,5 CHD accounts
for as much as 50% of neonatal infant mortality and is considered to be the most
common cause of infant death from a birth defect in the US.6 Up to one third of infants
born with CHD require surgical intervention early in their lives.7 The Consortium of the
Society of Thoracic Surgeons of Congenital Heart Surgery reported more than 60% of
infants born between July 2004 and June 2008 presented for surgical intervention in
the neonatal period (first 30 days of life).8 As a disease entity, CHD contributes not only
to the rate of infant mortality and to the prevalence of infant morbidity, but also to
chronic childhood health conditions and the associated healthcare costs.
With improvement in surgical technique, medical treatment, and nursing care
over the last few decades, there has been marked increase in the survival rate of
neonates with CHD. Between 1979 and 1997, CHD-related mortality declined more
than 39% in the US.1 Along with improved survival of neonates and infants undergoing
surgery for CHD, there has been a parallel emergence of co-morbidities in the
survivors. Although non-cardiac concomitant conditions requiring services from
pediatric subspecialists such as neurologists, pulmonologists, and orthopedics are
frequently seen,9 growth failure is one of the more common sequelae observed in
infants with CHD.10-12 More than 50% exhibit poor growth early in life and 30% fall
below the third percentile for weight on standard growth charts for age and gender
1

during infancy.13,14 The high prevalence of CHD, its contribution to infant morbidity and
mortality and the association with poor growth in infancy are ongoing challenges in
caring for these infants.
Growth is fundamental to pediatric care and often used as a gauge to measure
the infant’s health and well-being. For postsurgical infants with CHD, growth,
particularly weight gain, may also be a measure of surgical success and disease
management. Poor growth is common and well documented in infants with CHD both
before and after surgical intervention.10-12,14-18 Historically, poor growth also described
as growth failure has been ascribed to the population sample studied, making it difficult
to quantify and more difficult to generalize.19,20 Recent data suggest suboptimal
monitoring of growth measures, chronic medical problems that present with poor
growth, and socioeconomic factors may all be associated with growth failure but are
under-appreciated for their contribution to this condition.21,22 This may in part be
responsible for lack of an all-encompassing definition for growth failure adding to the
difficultly of diagnosis and treatment. Growth failure in infants with CHD can be the
result of feeding dysfunction resulting in inadequate nutrient intake, hemodynamic
alterations related to the underlying cardiac physiology, alterations in body
composition, neurologic immaturity, intercurrent illnesses, or disease severity.
There is no consensus on the definition of growth failure for infants and young
children with CHD. The same primary cardiac diagnosis can present differently based
on physiology and degree of hemodynamic impairment. This variability affects weight
gain and adds to the complexity of defining and identifying growth failure in this
population.
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Regardless of the etiology, growth failure can have a long-lasting effect on
overall health. Poor growth has also been associated with poor cognitive development
and deficits in neurodevelopmental outcomes that extend well into childhood and
adolescence.23-27 Further investigation into potential contributing factors, physiologic
associations, and possible modifiable elements that will lead to development of
strategies and interventions to prevent and/or minimize growth failure in these infants
will augment continued advances in surgical approach and improvements in care. A
better understanding of growth failure and its contributing factors can lead to
interventions to minimize or prevent its occurrence and improve health outcomes for
these infants. An investigation into the pattern of growth in infants with CHD compared
to healthy infants and exploring energy expenditure as a potential contributing factor to
the poor growth often seen is the focus of this dissertation. For the purposes of this
work, the terms ‘growth failure’ and ‘poor growth’ are synonymous and define the less
than adequate growth described throughout. Table 1 is a definition of terms.
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CHAPTER 1
The Problem: Growth Failure
Understanding Growth and Growth Failure
Whereas growth is fundamental to pediatric health and is often a measure of
overall well-being, poor growth, evidenced by a decrease in previously attained weight
and/or a negatively altered pattern of weight gain, is often associated with poor health,
chronic illness, and acute or chronic malnutrition. The first year of life is the time of the
most rapid ex utero growth. In infancy, lack of adequate energy, protein, and other
nutrient intake will likely result in adverse effects on growth and has potential to affect
neurodevelopmental maturation and behavior.24,28,29 Numerous studies have linked
poor growth in infancy with diminished intellectual ability, lower than average
Intelligence Quotient (IQ) and negative cognitive and behavioral outcomes in childhood
and adolescence.29-32
The typically developing infant gains between 20 to 30 grams per day in the first
6 months of life following an expected physiologic weight loss that may reach and can
exceed 10% of birth weight; in months 6 thru 12, weight gain slows to between 10 to 20
grams per day.13,33,34 Adequate nutrient intake in infancy is crucial to promote a positive
energy balance to support best potential for brain growth, neurologic development, and
physical maturation. In the second year of life, physical development changes and
weight gain further slows down to approximately 8 grams per day, while brain growth,
estimated by head circumference measurement is expected to increase an average of
0.33 centimeters (cm) per week and continue development late into childhood.24,35
Incremental gains in crown-to-heel length average 0.66 cm per week in the first 6
months of life, slowing to approximately 1.2 cm per month between 6 and 12 months of
age.13,24 Many neonates with CHD do not meet these parameters despite being born
4

full term and within the normal weight range for age and gender at birth.36,37 The
inability to attain and maintain growth parameters within an acceptable range for age
and gender, and/or a significant decrease from an established pattern of growth are
indicators of growth failure and if not corrected can lead to associated physical and
neurodevelopmental consequences.23,28-32,38
The definition of growth failure in the pediatric medical and/or nursing literature
is ambiguous and lacks a uniformly accepted approach to identify those infants at risk
for and who exhibit poor growth. In general, growth failure, most often called failure to
thrive (FTT), is defined as a disruption of the expected rate of growth, and can be the
prelude to significant morbidity and mortality.39 The most common description of FTT is
weight-for-age at or below the third to fifth percentile on more than one consecutive
weight-for-age assessment, or weight-for-age measurements that descend two or more
percentiles on a standard growth chart for age and gender.39-41 The definition of FTT
can also be specific to the infant, by describing weight gain that negatively deviates
from an established pattern of growth.41 Terms such as FTT, growth deficiency, growth
failure, growth faltering, poor growth, protein energy malnutrition, and under-nutrition,
are used interchangeably to describe less-than-adequate weight gain and poor
physical development seen in infancy and early childhood.13,41-44
Consequences of Growth Failure
Researchers have investigated prolonged, inadequate growth in early infancy
and its effect on cognitive and neurodevelopmental maturation. Bhoomika and
colleagues30 found growth failure, the result of poor nutrition, to be associated with
cognitive impairments, decreased acquisition of intellectual processes and poor
development of executive functions, including visual-spatial skills, working memory and
5

attention span. Dykman et al31 related deficits in growth measurements to deficiencies
in cognitive development, poor school achievement and adverse behavior in schoolaged children. In a population study of over 1,800 infants, McDougall and colleagues29
found growth failure in the first two months of life to be a risk factor for decreased
intellectual ability, lower IQ and developmental delay. Black et al45 reported cognitive
deficiencies inclusive of poor work habits, deficient math skills and behavioral problems
in 130 children with a known diagnosis of growth failure. These researchers also
describe attenuation of the cognitive and neurobehavioral impairments they observed
with early sustained intervention for both the child with growth failure and the primary
parental caregiver.45 Collectively these studies provide evidence of a strong association
between inadequate nutrient intake in early infancy and growth failure that have
implications for negative cognitive, neurodevelopmental and behavioral outcomes in
childhood.
Growth Failure in CHD
For the infant with CHD who has undergone neonatal surgery, poor growth is a
common co-morbidity that may have multiple factors contributing to its etiology. Factors
presumed to affect weight change and contribute to poor growth in these infants can
singularly or in combination include hemodynamic abnormalities related to cardiac
physiology and disease severity,13,32,46 inadequate nutrient intake,1,5,45 gastrointestinal
malabsorption,12,47-50 neurologic insults,12,36,47,51 and presumed increase in energy
expenditure.11,33,52-55 Additionally, these infants may have fluid losses as high as 10% to
15% compared to healthy infants, losses that can be attributed to tachypnea, poor fluid
intake, and the necessary use of diuretics for fluid regulation related to the underlying
cardiac disease.13,14,36,56 The dynamics of these factors and the impact they can have
6

pre- and/or postsurgical intervention may contribute to the growth failure often
exhibited by these infants. Figure 1 conceptualizes potential influencing factors on
growth for infants with CHD who have undergone neonatal surgery.
The relationship between growth failure and cardiac physiology has long been a
topic of discussion and investigation. The literature is robust with studies demonstrating
that infants with cyanotic lesions and postoperative single-ventricle (SV) physiology
exhibit more significant growth failure than infants with acyanotic disease or those with
two normally functioning ventricles.14,15,17,48,57-60 The degree of growth failure has been
associated with severity of hemodynamic impairment and/or the presence of heart
failure.13,60 A right-to-left or left-to-right shunt between either the atria or the ventricles
affects the infant’s hemodynamics and presumably has a negative effect on weight
gain contributing to growth failure in this population. Cyanotic defects, such as
Tetralogy of Fallot, Tricuspid Atresia and Hypoplastic Left Heart Syndrome are
associated with right-to-left shunting of blood flow at the ventricular level, resulting in
hypoxemia, often causing disturbances in both weight gain and attainment of
stature.13,60,61 Alternatively, acyanotic lesions, Aortic Stenosis, Coarctation of the Aorta
and Ventricular Septal Defect that manifest left-to-right shunting of blood at the atrial or
ventricular level affects weight rather than stature in the pre-operative stage of
disease.14,62 Regardless of the cardiac anatomy, growth failure for neonates and infants
with CHD is a significant challenge and warrants further investigation to identify causal
factors that if corrected may decrease morbidity and improve health outcomes.
In addition to growth measures of weight, length and head circumference, there
is high interest among healthcare providers and families in the behavioral,
neurodevelopmental and cognitive outcomes following surgical intervention for CHD.
7

An association has been established between growth failure and increased infant
irritability.63 Previous work from the parent study of this dissertation, reported infants
with CHD, particularly those with postoperative SV physiology were more likely to
exhibit growth failure, and have an increased level of irritability and negative
behaviors.64 Limperopoulos et al27 reported a combination of preoperative,
perioperative and postoperative factors influenced neurodevelopmental outcomes they
observed in infants 12 to 18 months after neonatal surgery for CHD. These
researchers found infant weight to be a significant predictor of motor and cognitive
deficits at 2 years of age.27 The Boston Circulatory Arrest Trial, a large longitudinal
study evaluated the neurodevelopmental status of participants at one, four and eight
years of age following infant surgery for CHD in which the participants were
randomized to either cardiac arrest or low-flow cardiopulmonary bypass for
intraoperative organ support.37,65-67 Study findings demonstrated moderate neurologic
deficits in motor coordination, and visual-motor integration, with mild deficits in speech
and language, thought to be associated with the use of cardiac arrest versus the low
flow cardiopulmonary bypass option during infant surgery.35,64-66 In a review of eight
studies, Snookes and colleagues68 reported consistent delay in cognitive and motor
development following surgery for CHD in early infancy. In an extensive review of the
literature reflecting progressive changes in cardiac surgery conducted by Shillingford
and Wernovsky23 a number of consistent themes regarding neurologic outcomes for
children with CHD who had undergone surgery in infancy were discovered. The
authors cite common themes of: 1) prevalence of attention deficits and behavior
problems; 2) deficits in visual-motor integration, visual-spatial challenges, and
abnormalities in speech and language development; 3) impaired development of
8

executive functioning; and 4) an association between intraoperative use of hypothermic
cardiac arrest and/or cardiopulmonary bypass with neurodevelopmental abnormalities
as sequela of surgery during infancy for cardiac disease.23 Predictors of these post
surgical deficits may or may not include the primary underlying cardiac defect, the
surgical approach, the decision for repair versus palliation, use of, type and duration of
intraoperative organ support, and/or the existence of an unknown pre-surgical
neurologic or genetic abnormality.25,38,68-71 Collectively, the evidence points to the need
for close, repeated assessment of growth measures and incremental
neurodevelopmental testing in infants and young children following surgical
intervention for CHD to promote early identification of neurodevelopmental problems
that may be minimized with prompt intervention(s).
Other factors that potentially influence weight gain and growth in infants with
CHD following neonatal surgery include metabolic rate and energy balance. A positive
energy balance, the direct result of energy intake that exceeds energy utilization, is
necessary to support somatic growth, neurobehavioral development, and long-term
health.72-74 The utilization of energy is divided between that required for basal metabolic
functions, thermal effects of digestion, requirements for tissue accretion, weight gain,
and the cost of physical activity.73 In general, neonates have a higher metabolic rate
compared to older children and adults, they require more kcal/kg of body weight.24,75 It
is postulated that infants with CHD, particularly those with heart failure, require an
increased energy intake to attain and maintain growth measurements within an

acceptable range for age and gender. This increased requirement is thought to be from
an increased oxygen consumption and inadequate caloric intake related to poor
feeding ability, gut dysmotility, and/or gastrointestinal malabsorption.14,76 Infants with
9

heart failure may be in a fixed hypermetabolic state prior to and/or immediately
following surgery, secondary to an increase in cardiopulmonary work and postoperative
stress.52,60 This hypermetabolic state, whether or not it is fixed, may affect the infants’
energy intake and energy utilization. Growth failure often seen in infants with CHD
following surgery may be the result of an imbalance between energy intake and energy
utilization, however, available data do not consistently support this
hypothesis.10,14,17,48,55,60 To date, studies suggesting an association between increased
energy expenditure and poor growth in infants and children with complex CHD have
yielded mixed results and are inconclusive due to study design, sample size, and a
heterogeneous participant group.52,61,73,77,78
Research endeavors specifically directed at examining energy intake and
utilization by neonates and infants with CHD prior to, immediately following, and at an
extended postsurgical time may elucidate the role energy balance and alterations in
have on weight gain and the subsequent growth of infants with CHD. With the known
association between growth failure and poor neurodevelopmental and cognitive
outcomes, it is essential to improve knowledge and understanding of factors
contributing to poor growth in this population. This will better prepare healthcare
providers to identify signs of growth failure, develop strategies toward decreasing the
incidence of poor growth in infants with CHD, and increase their ability to achieve
maximal growth, neurodevelopmental and intellectual potential.
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Methods
Parent Study: “Feeding Behaviors and Energy Balance in Infants with Congenital Heart
Disease”
The current body of work stems from a large, prospective study entitled:
“Feeding Behaviors and Energy Balance in Infants with Congenital Heart Disease”
(NIH/NINR R01 NR002093; MO1-RR00240; UL1-RR-024134), Principal Investigator:
Barbara Medoff-Cooper, PhD, RN, FAAN, heretofore known as the “parent study.”
Study approval was obtained from both Institutional Review Boards of The Children’s
Hospital of Philadelphia (CHOP) and the University of Pennsylvania, Philadelphia.
Study Design
The parent study design was a prospective, longitudinal design, from a single
center convenience sample.
Study Setting
The parent study is a single-institution investigation conducted at CHOP, a 430bed tertiary care facility serving the metropolitan Philadelphia area. During the study
period, March 2003 through May 2007, more than 1,100 neonates were admitted to the
Cardiac Intensive Care Unit (CICU) for evaluation of cardiac disease. The CICU staff
consists of surgeons, physicians, nurses, respiratory therapists and ancillary staff
specially trained in the intervention and therapeutic care of infants and children with
congenital and acquired cardiac disease.
Sample Population
Infants were screened following surgery and if eligible parents/guardians were
approached for enrollment. During the study period, 667 neonates in the CICU met
criteria; of these, 502 families were approached with 164 enrolled, a 33% consent rate.
11

The low rate of consent is multi-factorial and reflects challenges faced in this research
effort. These included absence of parent or guardian for consent, parental refusal to
participate, parental perceived study burden and inability or unwillingness to return to
CHOP for study visits. Additionally there were simultaneous ongoing studies in the
CICU competing for enrollment of the same group of infants. Many infants who met
criteria were from referral institutions where they would return for continued care and
thus be unavailable for study visits. Demographic characteristics of infants with CHD
who were not enrolled were similar to the enrolled group for gender, age, race,
ethnicity and post-operative physiology (Table 2). Healthy infants that served as the
control group were recruited from primary care practices affiliated with CHOP and selfreferral from surrounding communities. Demographic information on healthy infants not
enrolled was not available. Total enrollment in the parent study was 242 combined
cardiac and healthy infants. Race and ethnicity of the infants was assigned by parental
self-identification. Families unwilling or unable to return to CHOP for study visits were
not enrolled.
Eligibility criteria for all infants included >36 weeks post-menstrual age and birth
weight >2,500 grams. Infants with CHD who underwent surgical intervention during the
first 6 weeks of life, and did not have known multiple congenital, facial, chromosomal
and/or complex gastrointestinal anomalies or congenital and/or acquired neurologic
diagnoses were eligible for enrollment. Postoperative classification as SV or BV
physiology was completed in keeping with established standards.79
Data Acquisition
The study protocol commenced following hospital discharge when the infant
was 3-months of age. All data was obtained during study visits in the outpatient Clinical
12

and Translational Research Center and the Nutrition and Growth Lab at CHOP, by
trained research staff. The study protocol did not include assessment of type, amount,
or caloric density of daily nutrient intake or the rate of feeding advancement, the only
distinction referred to oral and device or device-assisted feedings. Dietary recall
diaries were provided to families as part of the study protocol, with instruction to record
nutrient intake for 3-days prior to or immediately following each study visit. The
research staff phoned families bi-monthly to inquire on the infant’s status and to
maintain interest in study participation.
Purpose and Specific Aims
The aim of the parent study was to develop a model to predict poor growth in
postsurgical infants with CHD through a over the first year of life. Sub-analyses of data
from the parent investigation has culminated in two studies that focus on examination
of factors related to growth and growth failure in infants with CHD who underwent
surgery in the first six weeks of life. These studies are presented in chapter two. The
first is a descriptive examination of the pattern of growth velocity over the first year of
life. This is a novel approach to describing growth as the study uses the new World
Health Organization (WHO) child growth velocity standards.80 The aim of this study
was to examine the pattern of growth velocity, inclusive of weight, length, and head
circumference for infants with CHD physiology compared to healthy controls. Growth
velocity, defined as the change in measure over time, is considered a superior
assessment of growth and more accurate than attained measures.80 Assessment of
growth velocity allows early detection of poor growth which can indicate alterations in
health and well-being or inadequate nutrient intake thereby facilitating early
identification of infants at risk for growth failure.80,81
13

The second study in chapter two examines resting energy expenditure (REE) in
infants with CHD compared to healthy infants at 3-months of age. There were two aims
to this study, 1) to examine differences in REE between infants with CHD compared to
healthy infants at 3 months of age and 2) to investigate if differences exist among
infants with CHD having SV versus BV physiology. This study uses WHO82 child
growth standards for weight, length and head circumference for children from birth to 5
years of age. These standards represent the best physiologic description of growth for
infants and children living in ideal environments.73,80,82
In chapter three, a grant application was developed and submitted for
consideration of an Early Independent Investigator award in response to a call from the
National Institutes of Health for educational-institution sponsored candidates. This
proposal embraces a modified approach to the principle of translational research.
Applying knowledge and skills gained through the course of this dissertation work in
the measurement and analysis of energy expenditure the goal of this proposal was to
identify differences between measured energy expenditure and the use of prediction
equations to prescribe caloric intake for children with acute lung injury requiring
mechanical ventilation. Using indirect calorimetry to measure energy expenditure will
allow tailored prescriptions for energy intake for critically ill children, in whom good
nutrition has a vital role in the process of recovery. Outcome measures for this
proposal include: 1) increased number of ventilator-free days, 2) decreased weight
loss, 3) decreased loss of lean body mass and 4) decreased length of stay. Table 2
describes the subject for each manuscript, and the grant proposal with the related
specific aim.
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Conclusion
Multiple factors have an influence on growth in infants with CHD following
neonatal surgery. Postsurgical physiology, severity of illness, feeding ability, neurologic
status, and energy expenditure may all contribute to growth failure that many of these
infants exhibit. The overall aim of this body of work is to explore the pattern of weight
change and investigate factors that contribute to or influence growth or growth failure in
the postsurgical infant with CHD. Monitoring growth velocity and understanding energy
needs and the relationship they share with adequate growth will enable first-line care
providers to better assess and intervene if growth failure is evident. Early recognition
and intervention of growth failure can potentially improve patient outcomes and overall
health. This work aims to initiate thoughtful collaboration among healthcare providers
to address the challenge(s) of growth failure in neonates and infants with CHD who
have undergone surgical intervention early in infancy.
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Table 1 Definition of Terms

Term

Definition

Acyanotic

Absence of cyanosis; oxygenated blood in
systemic circulations

Bi-ventricle (BV)

Normal two ventricle cardiac physiology; right
ventricle receives blood from the systemic
circulation pumps to the pulmonary circulation;
left ventricle receives blood from the pulmonary
circulation pumps to the systemic circulation

Congenital Heart Disease (CHD)

Anatomic or physiologic abnormality of the
heart occurring in utero

Congestive Heart Failure (CHF)

The heart cannot deliver adequate cardiac
output to meet the metabolic demands of the
body

Cyanotic

Deoxygenated blood in the systemic
circulation; pale or blue discoloration to skin,
face, hands, mucous membranes; related to
type of cardiac defect and resulting physiology

Growth Failure

Weight attainment or weight change velocity is
significantly below that of other infants of same
sex and age, based on a prescribed reference
standard

Infant

Child from 1 month to 12 months of age

Neonate

Newborn infant from birth to 30 days of life

Postsurgical physiology

Functional and anatomic physiology of blood
flow following surgical intervention for
congenital heart disease

Single Ventricle (SV)

Cardiac defect with one functioning ventricle for
pulmonary and systemic blood flow

Weight Attainment

Weight measured at a point in time; may be
assessed as kilogram or z-score

Weight Change Velocity

Weight measured over specified time
increments; may be assessed as kilograms, zscore, or percentiles over time
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Table 1 Comparison of infants with Congenital Heart Disease enrolled versus not
enrolled.*

Characteristics

Total Enrolled
% of n = 242

Not Enrolled
% of n = 338

Gender
Male
Female

61
39

76
57

Post Operative Physiologya
SV
BV

33
33

22
18

Healthy Controlsb

33

-

Racec
African-American
Asian
Caucasian
More than 1 Race
Unknown/No Response

18
1
69
6
6

9
<1
54
8

Ethnicityc
Non-Hispanic
Hispanic
Unknown/No Response

64
7
29

40
5
4

*Rounded % of total for each characteristic;
Physiology data for not enrolled subjects not confirmed
b
Comparable information on the unrecruited healthy infants was not available
c
Data for race and ethnicity in the not enrolled participants is incomplete; race and ethnicity is
assigned based on parent self-identification after enrollment
a
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Table 2 Manuscripts and Specific Aims

Chapter

Specific Aim

Chapter 2
Section 1
Growth Velocity over the First Year of Life
Following Neonatal Surgery for Complex
Congenital Heart Disease

To examine the pattern of growth
velocity of weight, length, and head
circumference for infants with
postsurgical classification as SV
physiology compared to healthy agematched controls over the first year of
life.

Section 2
Resting Energy Expenditure at 3 Months of To investigate differences in energy
Age in Infants with Complex Congenital
expenditure between infants with CHD
Heart Disease Following Neonatal Surgery who have a postoperative classification
as single-ventricle or two-ventricle
physiology as compared to healthy
age-matched controls at 3 months of
age.
Chapter 3
The Use of Indirect Calorimetry (IC) to
Measure Energy Needs in Mechanically
Ventilated Children with Acute Lung Injury

Description of manuscripts of the dissertation
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Use of IC derived measurements of energy expenditure to prescribe
nutrient intake specific to energy needs
in critically ill, mechanically ventilated
pediatric patients to increase
ventilation-free days, decrease hospital
stay, and improve overall outcome
following critical illness in a specific
patient population.

Figure 1 Conceptual Model of Potential Influences on Growth in CHD

Potential Influences on Growth
Infant
with complex
CHD

Influencing
Factors

Potentially
Modifiable
Factor

Severity of Disease

Growth

Weight Change Velocity
Weight for age z-score
Length for age z-score
HC for age z-score

Cardiac hemodynamic factors
Nutrient intake
Malabsorption
Neurologic factors
Surgical factors
Postoperative Course / Severity of Illness

Energy Balance

Conceptualization of the potential components and processes having an effect on growth in
infants following neonatal surgical intervention for CHD
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CHAPTER 2
Part 1
Growth Velocity over the First Year of Life Following Neonatal Surgery for
Congenital Heart Disease
Abstract
Background: Growth failure is well documented in infants with CHD. Poor growth in
infancy has an effect on cognitive and neurobehavioral development. Assessment of
growth velocity will identify infants at risk for growth failure.
Objective: To assess growth using World Health Organization (WHO) growth velocity
standards.
Study Design: A descriptive, a sub-analysis from a prospective, longitudinal study in a
large, metropolitan, cardiac center.
Methods: Infants with CHD were recruited following surgery. Healthy infants were from
primary practices and surrounding community. Growth measures were every 3 months.
WHO velocity z-scores were calculated. Student’s t-test was used to assess
differences between the groups.
Results: A total of 120 infants were included, 69 with CHD, 45% had SV physiology
and 55% with BV. There were 65% males, and 80% were Caucasian. Males and
females had statistically significant lower weight velocity z-score (males and females
p<0.001) for the birth to 3-month interval. In subsequent intervals there was no
difference in weight. Head circumference were different in velocity z-score only at the
birth to 3-month interval for males (males p<0.001; females (p<0.05). Other velocity zscores were not different.
Conclusion: Infants with CHD demonstrate poor growth velocity early in infancy. There
was no difference in growth velocity after the birth to 3-month interval. WHO growth
velocity standards are useful and may be more appropriate to assess growth patterns
for infants with CHD.

30

Definition of Terms

Term

Definition

Bi-Ventricle (BV)

Normal two-ventricle cardiac physiology

Congenital Heart Disease (CHD)

Anatomic and/or physiologic abnormality
of the heart occurring in utero, present at
birth

Growth Failure

Weight attainment or weight change
velocity that is significantly below
reference standards for age and gender

Growth Velocity

Weight, length, head circumference
measured over time; assessed as
centimeters, grams, kilograms, or zscore

Infant

Child from 30 days to end of 12 month

Neonate

Newborn child from birth to 30 days of
life

Postsurgical physiology

Functional and anatomical physiology of
blood flow following surgical intervention
for congenital heart disease

Single Ventricle (SV)

Cardiac defect with one functioning
ventricle for pulmonary and systemic
blood flow

Weight Attainment

Weight measured at a point in time;
assessed as centimeters, grams,
kilograms

31

Growth Velocity over the First Year of Life Following Neonatal Surgery for
Congenital Heart Disease
Introduction
Growth is often a gauge of an infant’s health, well-being and ability to thrive; it is
fundamental to pediatric healthcare. In the US, current American Academy of
Pediatrics guidelines recommend growth measurements at specified intervals to
monitor an infant’s growth progress.1,2 The first year of life is a period of rapid growth,
adequate nutrient intake is necessary to ensure acceptable weight gain, appropriate
increase in stature and support best potential for brain development. Alterations in
growth that occur during the first year and cause the infant to fall below reference
standards, may indicate growth failure and can have long-reaching consequences for
neurobehavioral development, cognitive function and school performance.3-6 Infants
with congenital heart disease (CHD), who have undergone surgery in the neonatal
period, often fall short of growth measurements that meet gender- and age-specific
reference standards, putting them at risk for consequences of the poor
neurodevelopment that can result from growth failure in early infancy.7-10
In 2006, the World Health Organization (WHO) introduced international child
growth standards consisting of z-scores and percentile curves for male and female
children aged 0 to 5 years.11 These standards describe how children should grow
versus a depiction of attained growth at a point in time. Experts agree that the WHO
standards represent the best physiologic growth for children under optimal
environmental conditions, with adequate nutrition, free of psychological, socioeconomic and ethnicity biases.11 As an adjunct to the growth standards, WHO
researchers developed growth velocity standards, introduced in 2009.12 Growth velocity
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defined as the change in measure over time, accounts for the normal individual pattern
of variability characteristic of saltatory, catch-up or slow-down growth.12 Growth
velocity can be highly variable, despite this it is considered a superior assessment and
may prove to be more appropriate than attained growth values. It allows for early
detection of infants and children at risk of falling below reference growth trajectories.
To better understand growth and growth patterns of infants with CHD following
surgery in the neonatal period, we examined growth velocity using the WHO
standards.12 The aim of this study is to describe the velocity of growth for weight,
length, and head circumference over the first year of life in 3-month intervals for infants
with CHD following neonatal surgery as compared to healthy infants of similar age and
gender. Table 1 is a definition of terms and abbreviations.
Study Design and Setting
This is a descriptive sub-analysis from a convenience sample of a prospective,
longitudinal study conducted at The Children’s Hospital of Philadelphia (CHOP),
between March 2003 and May 2007. Study approval was obtained from the CHOP
Institutional Review Board, and informed consent was obtained prior to
commencement of study procedures.
Study Sample
Neonates were recruited from the Cardiac Intensive Care Unit at CHOP.
Healthy infants from primary care practices affiliated with CHOP and the community at
large served as the control group. Eligible participants were 36 weeks post-menstrual
age with birth weight of > 2,500 grams. Birth data were extracted from records that
accompanied the infant to CHOP or by parental report for healthy infants. Infants with
known or overt chromosomal abnormalities, multiple congenital and/or facial
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anomalies, or complex gastrointestinal or congenital and/or acquired neurologic insults
were not eligible as these factors are associated with poor growth. Infants with CHD
were classified as single ventricle (SV) or biventricular (BV) physiology in the usual
manner.13 Race and ethnicity were assigned based on parent self-identification.
Study Methods
All study visits were conducted at CHOP in the Clinical and Translational
Research Center and the Nutrition and Growth Lab. Study measurements were
obtained by research personnel using standard protocol.14 Design of the larger study
included study visits in 3-month intervals beginning at 3-months of age through 12
months. Goal timing of study visits was set within 2 weeks before or after the infant’s
birth date. Infants who attended a minimum of two of five study visits, one being the 3month visit and had birth weight data were included in this analysis.
Weight was measured in kilograms (kg) using a Scale-Tronix (Scale-Tronix,
White Plains, NY, USA) infant pan scale, accurate to 5 gm. Recumbent length
measured in centimeters (cm) was obtained using an infant length board (Holtain
Limited, Crymuch, UK) accurate to 0.1 cm. Head circumference was measured using
a non-stretchable tape and measured to 0.1 cm (McCOY Health Science Supply,
Maryland Heights, MO, USA). Measurements were obtained in triplicate, and the
calculated mean used for analysis. Using WHO standards,11,15 measures of weight,
length, and head circumference were converted to z scores. Calculations for weight
growth velocity were calculated in four, 3-month intervals. Velocities for length and
head circumference were calculated for three intervals owing to incomplete birth data
for these measures.
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Statistical Analysis
All analyses were completed using the SAS V9.2 (SAS Institute, Cary, NC)
statistical analysis program. Statistical significance was determined at the p<0.05 level.
Descriptive statistics of the means, standard deviations, medians, and minimum and
maximum values for each measure were calculated. Distribution plots were used to
assess normality of the data.
Velocity for each growth parameter for each infant for each time interval was
calculated using the equation:
unit of measure/day = Δ in growth parameter ÷ length of interval in days,
where the change (Δ) in growth parameter is the difference between the measured
weight, length or head circumference obtained at two contiguous study visits. That
change was then divided by the time interval in days between study visits. The result is
the unit of measure/day. An example of calculation for weight velocity is:
20.8 gm/day = 5800 gm – 3550 gm ÷ 108 days,
where 5800 gm is the 3-month visit weight, 3550 gm is the birth weight, 108 days is the
number of days between birth and the 3-month study visit, resulting in 20.8 gm/day
weight change over 108 days.
The next step was to correct the velocity to the specified 3-month interval of the
study protocol. This was done by multiplying the derived unit of measure by 91.2 to
account for months with 30 and 31 days. The result is a value representing the change
specific to a 3-month interval. Using the example above:
1897 gm over 3 months (total weight change) = 20.8 gm/day x 91.2 days.
The same procedures were repeated to calculate the velocity of length and head
circumference for each infant for each time interval.
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Velocity z-score for each growth parameter was then calculated using the WHO
equations12 based on 3-month intervals, 0 – 3, 3 – 6, 6 – 9, and 9 – 12, as specified in
the larger study protocol. To enable comparison of the groups, z-scores were
calculated using the lambda (L), mean (M), standard deviation (S), and delta values
specified in the WHO procedure for the 3-month intervals indicated.12 The WHO
velocity z-score was calculated using the equation:
12

,

where

represents the growth parameter increment (weight, length or head

circumference) for t, the visit age interval; LMS values are from the WHO tables for 3month intervals by gender. Once velocity z-scores were calculated for all parameters,
two-sided Student’s t-test was used to compare differences at each interval between
healthy infants to infants with CHD by gender.
Results
There were 130 infants who met inclusion criteria. Three infants with CHD died
prior to study completion due to complications of their cardiac disease. Five healthy
infants did not have birth weight data and two families withdrew from study
participation. There were 120 infants included at the initiation of this analysis. Of these,
69 were infants with CHD, 31 (45%) with SV physiology, 38 (55%) with BV physiology;
51 were healthy infants. The distribution of diagnoses for infants with CHD is presented
in Table 2. Data are presented by gender with healthy infants compared to infants with
CHD, as small sample size did not permit examination of the data in infants with CHD
by physiology. The number of participants at each visit, for each measure and each
interval was determined. Study sample demographics are presented in Table 3. The
data are grouped and presented by growth parameter, illustrating the group mean,
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WHO z-score, parameter measurement change over time and WHO velocity z-score
(Tables 4, 5, 6, and 7).
Birth weight in grams and z-score were not different among the groups. The
mean attained weight was significantly less for males with CHD compared to healthy
males (5517 gm, z-score -1.4, p<0.001) at 3-months, with a statistically significant
decreased weight change in the birth to 3 month interval (2015 gm, p<0.001). The
weight velocity z-score further demonstrated this decreased weight change, z-score
-1.82, p<0.001 compared to healthy males. This trend of decreased mean attained
weight continued and remained negative and statistically significant in males for each
time point (Table 6). There was a 20% drop in attendance from the 3-month to 6-month
visit and a 22% drop from the 6-month to 9-month visit. At 12 months, males with CHD
had 89% attendance, a 40% increase from the 9- month visit. The attained weight at 12
months although still significantly less than healthy in males (9398 gm, p=0.04) showed
improvement. There was no difference in weight change or weight velocity z-score
after the birth to 3-month interval.
Females with CHD demonstrated a statistically significant decrease in attained
weight (5422 gm, p=0.02) at the 3-month visit compared to healthy females. The birth
to 3-month interval weight change (1764 gm) and weight z-score velocity (-1.8) were
also significantly lower (p<0.001) than for healthy females. Attained weight, weight zscore, weight change, and weight velocity z-score were not different between females
with CHD and healthy females at any other time point or interval. Females with CHD
represented the smallest number of participants at each study visit. Table 7 compares
healthy females to females with CHD for each growth parameter.
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Males with CHD demonstrated significantly lower attained length at each study
visit compared to healthy males; the length z-score, length change and length velocity
z-score were not different (Table 6). Head circumference showed a similar pattern to
weight in males with CHD compared to healthy males, with the exception of the 12month visit where attained head circumference was not different between the groups.
The head circumference velocity z-score for males (0.1) was negatively significant at
the birth to 3-month interval, p<0.01. No other intervals were different from those in
healthy males.
Length for females with CHD was not different from healthy females at any visit
or any time interval. The attained measure for head circumference in females with CHD
was significantly lower (39 cm, p<0.05) than in healthy females at the 3-month visit, no
difference was demonstrated in attained measurement, head circumference z-score,
head circumference change or head circumference velocity z-score for any other time
point or time interval. Females with CHD demonstrated a drop in attendance of 26%
from the 3 to 6-month visit, 29% from the 6 to 9-month visit and an increase of 43%
from the 9 to 12-month visit, which has a critical impact on the findings. In addition,
there was more than 20% missing data for each measurement across the study
critically affecting the findings and limiting the conclusions that can be derived.
Discussion
In this study, using the new WHO growth and growth velocity standards to
evaluate infants with CHD compared to healthy infants of similar age and gender, we
demonstrate decreased attained weight, decreased interval weight change and
negative weight velocity z-scores in both males and females with CHD at 3-months of
age. The small sample size and missing data necessitate cautious interpretation of
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these findings. Despite this, these data give promise for better understanding of the
pattern of growth in infants with CHD who have undergone neonatal surgery.
Infants are expected to gain between 20 and 30 grams/day in the first 6
months of life following a physiologic weight loss in the first days of life up to and
exceeding 10%.16-18 This rate of growth is different in exclusively breastfed infants.17
From these data, it appears that on average infants with CHD are at the lower end of
this expected range for weight gain or do not meet it, particularly in the first 3-months of
life. In our study, males with CHD showed a mean weight change in the birth to
3- month interval of 2015 gm, approximately 22gm/day; the mean weight change in
healthy males was approximately 29 gm/day. Using the WHO growth velocity
standards, this change is equal to a weight velocity z-score of -1.82 and corresponds to
the 3rd to 5th percentile of weight velocity for age and gender. In the same birth to 3month period, females with CHD demonstrated a weight change of 19 gm/day
compared to 27 gm/day in healthy females; they too are in the 3rd to 5th percentile with
a corresponding weight velocity z-score of -1.8. For the birth to 3-month interval, both
females and males with CHD demonstrated growth velocity below the 5th percentile by
WHO standards. Although these are the mean values of the respective groups, it is the
low weight velocity z-scores in conjunction with low attained weight that are of concern.
These values represent significant growth failure at this time interval, supporting the
existing evidence that describes poor weight gain in infants with CHD in early infancy.
The attained weight in males with CHD remained statistically significant and below that
of healthy males throughout the study period. Following the birth to 3-month interval
weight change and weight velocity z-scores were not different for males or females
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with CHD compared to healthy infants of the same gender, suggesting catch-up growth
occurs subsequent to 3-months of age.
Attained length for males with CHD was significantly below that of healthy
males at each study visit (Table 6) however, the change in length and length velocity zscore were not different, suggesting that although length at 3-months of age is lower
than that in healthy infants, the rate of increase is the same. Length for female infants
with CHD was not different from healthy females in our study sample. Several studies
of infants with CHD report linear growth delay in early infancy, with catch up growth for
length commencing later in infancy and progressing at a slower rate than weight catch
up growth.10,19,20 These studies suggest that delayed attainment of length in infants with
CHD following neonatal surgery is reversible.
Head circumference is the best determinant of brain growth.21,22 In males with
CHD in our study sample, attained head circumference was decreased from that of
healthy males with no difference by 12 months of age. Females with CHD
demonstrated a negative statistically significant difference only at 3-months and only
for the attained head circumference measurement (39 cm, p=0.01); this finding is likely
skewed due to small sample size. Research suggests that prenatally, infants with CHD
have smaller brain volume and decreased brain growth; this low volume presents at
birth as small head circumference and may indicate global neurologic immaturity.21-23
This decreased brain volume and the potential for slow brain growth can have a direct
effect on neurodevelopment, cognition, and behavior in childhood.22,24
Monitoring growth parameters is an important component of care for infants and
young children, particularly infants with CHD who have undergone neonatal surgery.
Although limited, the data presented show significantly decreased growth in males and
40

females at 3-months of age with promise for catch up in late infancy. We used WHO
standards for growth11 and growth velocity12 to evaluate these data as it is believed
these standards provide a more precise assessment of how growth is occurring over
time compared to how it has occurred at a point in time. Ross and colleagues25
demonstrated a downshift or poor weight attainment in early infancy, at 2 to 4 months
of age, and found to be predictive of later poor growth despite an interval period of
growth recovery. These researchers suggest that healthcare providers use
acceleration and deceleration standards to identify patterns of growth in infants at risk,
initiate stringent monitoring procedures and provide early interventions for those infants
whose pattern of growth in early infancy suggests growth failure.25
Poor growth in early infancy has been associated with infant irritability, cognitive
impairments, delayed development of executive functions, developmental delay, poor
school achievement, and deficits in motor, speech and language skills.4,5,26,27 In a
population based study, Gale et al28 reported prenatal head growth and head growth
during infancy to be particularly important determinants for subsequent intelligence,
further, they found head growth after infancy did not appear to compensate for
decreased growth during infancy. McDougall et al4 studied over 1800 infants with
documented poor growth in the first months of life and found an association to
decreased intellectual ability and lower IQ at school age. These studies present
evidence of an association between poor growth in infancy and negative impact on
neurodevelopment and intelligence in childhood.
The data presented here, demonstrate growth failure in the infants with CHD.
Contributing factors that may have a role in poor growth evidenced in infants with CHD
include inadequate energy intake to promote a positive energy balance,29-32
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gastrointestinal tract abnormalities,33,34 neurologic immaturity,21,23,35 and feeding
dysfunction.36-38 Regardless of the etiology, the potential short and long-term
consequences of poor growth can be detrimental to the infant and are a focus of
interest. Reviews of studies investigating neurobehavioral and neurodevelopmental
outcomes following surgery for CHD have consistently found reports of delay in
cognitive and motor development, attention deficits and altered development of speech
and language skills.6,39-41 These documented consequences of growth failure and the
impact they can exert on growth and long-term intellectual development are ample
cause to further investigate contributors to poor growth in this population and seek
viable interventions to minimize its occurrence.
Study Limitations
Limitations include this being a convenience sample from a single center with
high illness acuity of cardiac disease. There was a large amount of missing data
resulting in small sample size. Dietary intake records were not available to assess
energy intake simultaneously with growth in these infants. All birth data were parent
report or extracted from the transfer record that accompanied the infants with CHD.
Some bias may exist in that families who enrolled were motivated to participate in a
complex study protocol.
Conclusion
Poor growth is a common morbidity in infants with CHD who have undergone
neonatal surgery. In this study, the use of the WHO growth and growth velocity
standards presents a novel approach to examine growth in our cohort of infants with
CHD. We found a pattern of poor growth in the birth to 3-month interval across gender,
a time usually associated with rapid growth and development. From these limited data,
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growth in all measures appears to begin catch-up following the initial interval of poor
growth. Further study with a larger sample is and fewer missing data points is
necessary for a better evaluation of these findings. However, these data are important
and may be the first to use the WHO growth velocity standards to evaluate growth in a
cohort of chronically ill infants. Use of this methodology may assist providers in early
identification of poor growth in infants with CHD following surgery in the neonatal
period and facilitate timely interventions to prevent or minimize growth failure,
decreasing the risk for and potential of negative cognitive and neurodevelopmental
sequelae associated with poor growth in early infancy, particularly in infants with CHD.
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Table 2 CHD Primary diagnosis of infants with Congenital Heart Disease

Primary Diagnosis

Postsurgical Physiology

Single Ventricle
% of N = 31
Hypoplastic Left Heart Syndrome

59

Tricuspid Atrestia

16

Bi-Ventricle
% of N = 38

Double Inlet Left Ventricle

6

L-Transposition of Great Arteries

3

D-Transposition of Great Arteries

6

47

Double Outlet Right Ventricle

3

3

Valvular Pulmonary Atresia

6

3

Coarctation of the Aorta

21

Tetrology of Fallot

11

Interrupted Aortic Arch

5

Truncus Arteriosus

2

Aortopulmonary Window

2

Valvular Aortic Stenosis

2

Total Anomalous Pulmonary Venous
Return

3

Distribution of diagnoses across sample of infants with CHD, with postsurgical cardiac
classification
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Table 3 Study sample demographics

Healthy Infants

Infants with Congenital Heart Disease

Single Ventricle

Bi-Ventricle

N

51

31

38

Gender
Female
Male

19
32

8
23

15
23

Race
AA
Asian
Caucasian
>1
Not Reported

13
1
33
2
2

4
26
1

37
1
-

Ethnicity
Hispanic
Non-Hispanic
Not Reported

2
42
6

2
21
8

3
25
9

Gender, race, and ethnicity distribution of study sample.
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Table 4 Mean (SD) growth parameters, healthy females and males

Healthy Females

Healthy Males

Time

Birth

3

6

9

12

Birth

3

6

9

12

n

19

19

19

17

19

32

32

32

24

27

Age
(d)

0

98
(15)

194
(18)

270
(11)

374
(17)

0

93
(9)

191
(15)

276
(14)

370
(17)

Wta
gm

3304
(0.5)

5984
(0.8)

7379
(0.8)

8376
(1.0)

9195
(1.1)

3576
(0.6)

6272
(0.6)

7969
(1.0)

9213
(0.7)

9952
(1.0)

zscore

0.1
(1.1)

-0.1
(1.0)

-0.1
(0.9)

0.1
(1.0)

0.1
(0.9)

0.4
(1.1)

-0.2
(0.8)

-0.1
(1.0)

0.3
(0.6)

0.2
(1.0)

Wt Δ,
b
gm

2461
(562)

1419
(393)

903
(460)

918
(303)

2653
(601)

1570
(404)

1194
(546)

875
(377)

Wt
c
z-vel

-0.3
(1.1)

-0.2
(1.0)

-0.2
(1.3)

0.6
(0.9)

-0.6
(1.1)

-0.1
(1.0)

0.5
(1.7)

0.3
(1.1)

Lt
cm

61
(2.8)

66
(2.1)

70
(2.3)

73
(1.2)

62
(2.4)

69
(2.8)

73
(3.0)

77
(3.0)

zscore

-0.31
(1.3)

-0.0
(0.9)

0.3
(1.3)

-0.3
(0.8)

0.3
(1.1)

-0.0
(1.0)

0.6
(1.3)

0.3
(1.2)

Lt Δ,
b
Gm

5.5
(2.1)

-0.1
(1.0)

3.7
(1.4)

5.5
(2.1)

4.6
(1.5)

3.4
(1.3)

Lt
c
z-vel

-0.5
(2.0)

-0.3
(1.6)

-0.2
(1.5)

-0.2
(1.1)

0.3
(1.5)

-0.5
(1.5)

a

a

HC
cm

40
(1.4)

43
(1.1)

45
(1.3)

45
(1.0)

41
(1.3)

44
(1.2)

46
(1.1)

47
(1.3)

zscore

0.5
(1.0)

0.5
(0.8)

0.8
(1.0)

0.4
(0.7)

0.4
(1.1)

0.3
(0.8)

0.5
(1.0)

0.5
(1.0)

HC Δ,
b
Gm

2.7
(0.5)

1.8
(0.7)

0.7
(1.3)

2.7
(0.6)

1.7
(0.6)

1.2
(0.5)

HC
c
z-vel

-0.5
(2.0)

-0.3
(1.6)

-0.2
(1.5)

-0.2
(1.1)

0.3
(1.5)

-0.5
(1.5)

*Weight for birth data only; Parameter means (SD), Parameter interval Δ (SD), Parameter
interval velocity z-score
a

b
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c

Table 5 Mean (SD) growth parameters, females and males with CHD

Males with CHD

Females with CHD
Time

Birth

3

6

9

12

Birth

3

6

9

12

n

23

23

17

12

21

46

46

37

29

41

Age
(d)

0

99
(16)

192
(17)

272
(12)

375
(17)

0

96
(13)

189
(15)

277
(16)

380
(19)

Wt
gm

3491
(0.5)

5422
(0.7)

6982
(0.9)

8217
(1.0)

9119
(1.1)

3396
(0.5)

5517
(0.9)

7257
(1.0)

8303
(1.1)

9398
(1.1)

zscore

0.0
(1.0)

-0.9
(1.0)

-0.6
(1.1)

-0.1
(1.0)

0.0
(1.0)

0.1
(1.0)

-1.4
(1.2)

-1.0
(1.1)

-0.7
(1.2)

-0.4
(1.1)

a

§

‡

¥

‡

§

Wt Δ,
b
gm

1764
(545)

1524
(246)

1056
(296)

901
(424)

2015
(606)

‡

1607
(347)

1080
(493)

833
(506)

Wt
zc
vel

-1.8
(1.3)

‡

0.1
(0.7)

0.3
(0.8)

0.5
(1.2)

-1.82
(1.2)

‡

0.0
(1.0)

0.2
(1.4)

0.2
(1.5)

Lt
cm

60
(2.5)

66
(3.4)

71
(2.8)

74
(3.0)

60
(2.8)

66
(2.5)

70
(2.9)

75
(2.8)

zscore

-0.4
(1.2)

-0.6
(1.4)

0.3
(1.2)

0.0
(1.1)

-0.4
(1.2)

-0.7
(1.1)

-0.8
(1.2)

-0.6
(1.2)

Lt Δ,
b
gm

6.5
(1.3)

4.8
(1.5)

3.8
(1.2)

6.4
(1.5)

4.7
(1.0)

3.3
(2.0)

Lt
zc
vel

0.5
(1.2)

0.4
(1.5)

-0.1
(1.3)

0.1
(1.3)

0.4
(1.0)

-0.2
(1.4)

a

a

‡

§

‡

‡

¥

§

‡

§

§

HC
cm

39
(1.1)

43
(1.0)

45
(1.6)

46
(1.6)

40
(1.7)

43
(1.4)

45
(1.7)

46
(1.6)

zscore

-0.34
(1.1)

-0.2
(0.9)

-0.4
(1.3)

0.0
(1.2)

-0.9
(1.4)

-0.3
(1.1)

-0.3
(1.4)

-0.0
(1.3)

3.0
(0.4)

1.6
(1.0)

1.3
(0.7)

3.3
(0.7)

§

1.7
(1.0)

1.4
(0.8)

0.5
(1.2)

0.4
(1.5)

-0.1
(1.3)

0.1
(1.3)

HC
Δ,
b
gm

¥

0.4
-0.2
HC
(1.0)
(1.4)
c
z-vel
a
b
c
*Weight for birth data only; Parameter means (SD), Parameter interval Δ (SD), Parameter
§
¥
‡
interval velocity z-score; Student’s t-test significance levels p<0.05, p<0.01 p<0.001
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Table 6 Mean (SD) growth parameters, healthy males and males with CHD

Males with CHD

Healthy Males

Time

Birth

3

6

9

12

Birth

3

6

9

12

n

32

32

32

24

27

46

46

37

29

41

Age
(d)

0

93
(9)

191
(15)

276
(14)

370
(17)

0

96
(13)

189
(15)

277
(16)

380
(19)

gm

3576
(0.6)

6272
(0.6)

7969
(1.0)

9213
(0.7)

9952
(1.0)

3396
(0.5)

5517
(0.9)

7257
(1.0)

8303
(1.1)

zscore

0.4
(1.1)

-0.2
(0.8)

-0.1
(1.0)

0.3
(0.6)

0.2
(1.0)

0.1
(1.0)

-1.4
(1.2)

-1.0
(1.1)

-0.7
(1.2)

Wt Δ,
b
gm

2653
(601)

1570
(404)

1194
(546)

875
(377)

2015
(606)

1607
(347)

1080
(493)

Wt
c
z-vel

-0.6
(1.1)

-0.1
(1.0)

0.5
(1.7)

0.3
(1.1)

-1.82
(1.2)

‡

0.0
(1.0)

0.2
(1.4)

Lt
cm

62
(2.4)

69
(2.8)

73
(3.0)

77
(3.0)

60
(2.8)

66
(2.5)

70
(2.9)

75
(2.8)

zscore

0.3
(1.1)

-0.0
(1.0)

0.6
(1.3)

0.3
(1.2)

-0.4
(1.2)

-0.7
(1.1)

-0.8
(1.2)

-0.6
(1.2)

Lt Δ,
b
gm

5.5
(2.1)

4.6
(1.5)

3.4
(1.3)

6.4
(1.5)

4.7
(1.0)

3.3
(2.0)

Lt
c
z-vel

-0.2
(1.1)

0.3
(1.5)

-0.5
(1.5)

0.1
(1.3)

0.4
(1.0)

-0.2
(1.4)

Wta

a

a

‡

¥

‡

9398
§

(1.1)

‡

‡

‡

‡

¥

§

§

-0.4
(1.1)
833
(506)
0.2
(1.5)
§

HC
cm

41
(1.3)

44
(1.2)

46
(1.1)

47
(1.3)

40
(1.7)

43
(1.4)

45
(1.7)

46
(1.6)

zscore

0.4
(1.1)

0.3
(0.8)

0.5
(1.0)

0.5
(1.0)

-0.9
(1.4)

-0.3
(1.1)

-0.3
(1.4)

-0.0
(1.3)

HC Δ,
b
gm

2.7
(0.6)

1.7
(0.6)

1.2
(0.5)

3.3
(0.7)

§

1.7
(1.0)

1.4
(0.8)

HC
c
z-vel

-0.2
(1.1)

0.3
(1.5)

-0.5
(1.5)

0.1
(1.3)

¥

0.4
(1.0)

-0.2
(1.4)

*Weight for birth data only; Parameter means (SD), Parameter interval Δ (SD), Parameter
§
¥
‡
interval velocity z-score; Student’s t-test significance levels p<0.05, p<0.01 p<0.001
a

b
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Table 7 Mean (SD) growth parameters, healthy females and females with CHD

Females with CHD

Healthy Females

Time

Birth

3

6

9

12

Birth

3

6

9

12

n

19

19

19

17

19

23

23

17

12

21

Age
(d)

0

98
(15)

194
(18)

270
(11)

374
(17)

0

99
(16)

192
(17)

272
(12)

375
(17)

Wta
gm

3304
(0.5)

5984
(0.8)

7379
(0.8)

8376
(1.0)

9195
(1.1)

3491
(0.5)

5422
(0.7)

6982
(0.9)

8217
(1.0)

9119
(1.1)

zscore

0.1
(1.1)

-0.1
(1.0)

-0.1
(0.9)

0.1
(1.0)

0.1
(0.9)

0.0
(1.0)

-0.9
(1.0)

-0.6
(1.1)

-0.1
(1.0)

0.0
(1.0)

Wt Δ,
b
gm

2461
(562)

1419
(393)

903
(460)

918
(303)

1764
(545)

1524
(246)

1056
(296)

901
(424)

Wt
c
z-vel

-0.3
(1.1)

-0.2
(1.0)

-0.2
(1.3)

0.6
(0.9)

-1.8
(1.3)

‡

0.1
(0.7)

0.3
(0.8)

0.5
(1.2)

Lt
cm

61
(2.8)

66
(2.1)

70
(2.3)

73
(1.2)

60
(2.5)

66
(3.4)

71
(2.8)

74
(3.0)

zscore

-0.31
(1.3)

-0.0
(0.9)

0.3
(1.3)

-0.3
(0.8)

-0.4
(1.2)

-0.6
(1.4)

0.3
(1.2)

0.0
(1.1)

Lt Δ,
b
Gm

5.5
(2.1)

-0.1
(1.0)

3.7
(1.4)

6.5
(1.3)

4.8
(1.5)

3.8
(1.2)

Lt
c
z-vel

-0.5
(2.0)

-0.3
(1.6)

-0.2
(1.5)

0.5
(1.2)

0.4
(1.5)

-0.1
(1.3)

a

a

§

‡

§

HC
cm

40
(1.4)

43
(1.1)

45
(1.3)

45
(1.0)

39
(1.1)

43
(1.0)

45
(1.6)

46
(1.6)

zscore

0.5
(1.0)

0.5
(0.8)

0.8
(1.0)

0.4
(0.7)

-0.34
(1.1)

-0.2
(0.9)

-0.4
(1.3)

0.0
(1.2)

HC Δ,
b
Gm

2.7
(0.5)

1.8
(0.7)

0.7
(1.3)

3.0
(0.4)

1.6
(1.0)

1.3
(0.7)

HC
c
z-vel

-0.5
(2.0)

-0.3
(1.6)

-0.2
(1.5)

0.5
(1.2)

0.4
(1.5)

-0.1
(1.3)

*Weight for birth data only; Parameter means (SD), Parameter interval Δ (SD), Parameter
§
‡
interval velocity z-score; Student’s t-test significance levels p<0.05, p<0.001
a

b

55

c

Figure 1 Weight velocity z-score by gender

Graph illustrating weight velocity z-score by gender in 3-month intervals.
Student’s t-test to compare healthy to infants with CHD of same gender: males -1.82, p<0.001;
females -1.80, p<0.001
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Figure 2 Length velocity z-score by gender

Graph illustrating illustrating length velocity z-score by gender in 3-month intervals. Birth
length data not available. No difference between the groups. Student’s t-test to compare
healthy to infants with CHD of same gender.
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Figure 3 Head circumference velocity z-score by gender

Graph illustrating head circumference velocity z-score by gender in 3-month intervals.
Birth length data not available. No difference between the groups. Student’s t-test to
compare healthy to infants with CHD of same gender.
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CHAPTER 2
Part 2
Resting Energy Expenditure at 3-Months of Age in Infants Following Neonatal Surgery
for Congenital Heart Disease
Abstract
Background: Growth failure is well recognized in infants with Congenital Heart Disease
(CHD). Poor growth can impact physiologic and neurodevelopmental outcomes.
Study Aim: To determine resting energy expenditure (REE), body composition and
weight at 3-months of age in infants with CHD. A secondary aim was to identify
predictors of REE.
Design and Methods: Sub-analysis of a prospective, single center cohort with single
ventricle (SV) and bi-ventricle (BV) physiology. Anthropometric measurements, REE,
and body composition were obtained at 3-months. Analysis included chi-square for
association between categorical variables, t-tests, ANOVA and ANCOVA to compare
differences. Pearson’s correlation was used to examine linear relationships.
Results: Of the 44 infants with CHD, 18% had SV physiology. Infants with SV and BV
physiology had lower weight for age z scores compared to healthy infants -1.1 for SV
(p=0.001) and -1.0 for BV (p<0.005). Infants with SV and BV physiology had lower %
body fat compared to healthy controls (SV 23.7%; BV 22.7%) but had similar REE as
the control group. Fat free mass and infant age were positively correlated with REE.
Conclusion: Cardiac physiology was not a predictor of REE kcal in this study sample.
Infants with CHD had lower weight for age z score and decreased % body fat at 3
months of age. These data suggest that inadequate caloric intake contributes to growth
failure in infants with CHD.
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Table 1 Definition of Terms

Abbreviation

Term

BV

Biventricular Physiology

CHD

Congenital Heart Disease

FM

Fat Mass, kg

FFM

Fat Free Mass, kg

REE

Resting Energy Expenditure, Kcal/day

%Sch

Schofield equation percent predicted

SV

Single Ventricle Physiology

%WHO

WHO equation percent predicted
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Introduction
Growth failure is well recognized in infants with Congenital Heart Disease
(CHD). Despite surgical intervention in the neonatal period, more than 50% of these
infants exhibit inadequate growth,1,2 with greater than 30% falling below the third
percentile for weight early in life.3 Poor somatic growth in infancy has the potential to
impact physiologic and neurodevelopmental outcomes well into childhood and
adolescence.4,5 The etiology of poor growth in infants following neonatal surgery for
CHD is likely multi-factorial and may in part result from inadequate energy intake or an
increase in energy expenditure, resulting in an energy imbalance. Strong correlations
have been demonstrated between growth failure early in life and long term cognitive
deficiencies, including poor arithmetic performance, attention deficit, aggressive
behavior and poor social and emotional development.4,5 We reported a high rate of
growth failure at hospital discharge in infants with both single ventricle (SV) physiology
and biventricular (BV) circulation following neonatal surgery.6,7 Poor weight gain in the
post-operative period prior to hospital discharge was associated with post-operative
complications, and timing of initiation of nutrient intake. These findings are similar to
other reports that suggest infants with CHD receive less than adequate caloric intake
to support normal weight gain and growth.8-14
There have been multiple investigations into the energy needs of infants with
CHD in the pre-operative and post-operative period. The results are mixed and may be
due to study design, small sample size, or a diverse sample of infants with cardiac
disease.15-23 The primary aim of this study was to determine whether there are
differences in resting energy expenditure (REE), body composition, and somatic
growth at 3-months of age in infants who have undergone neonatal surgery for CHD
compared to healthy infants, and whether differences are present among infants with
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CHD classified postoperatively as SV versus BV physiology. A secondary aim was to
identify predictors of REE in infants with CHD compared to healthy infants.
Study Design and Setting
This is a sub-analysis from a prospective, cohort study investigating predictors
of growth in postoperative infants with CHD conducted at The Children’s Hospital of
Philadelphia (CHOP) from March 2003 through May 2007. Study approval was
obtained from the CHOP Institutional Review Board. Informed consent was obtained
from a parent or guardian of each participant prior to initiation of study protocol.
Sample Population
Study participants were recruited from the Cardiac Intensive Care Unit at
CHOP. Healthy infants served as the control group and were recruited from primary
care practices, and the community at large. Eligibility for all infants included postmenstrual age > 36 weeks and birth weight > 2500 grams. Infants with CHD who
underwent cardiac surgical intervention during the neonatal period (first 30 days of life)
and did not have known multiple congenital, facial, chromosomal or complex
gastrointestinal anomalies or congenital and/or acquired neurological insults were
eligible. Infants were classified postoperatively as SV or BV physiology in accordance
with established standards.24 Race and ethnicity of the infants were assigned by the
parent’s self-identification. Families unable or unwilling to return to CHOP for study
visits were not enrolled.
Study Measurements
Measurements were obtained during the 3-month outpatient visit to the Clinical
and Translational Research Center (CTRC). The measurements were obtained by
research personnel according to standard protocol.25
Anthropometric Measurements
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Weight, length and head circumference measurements were obtained prior to
measurement of REE and body composition on all participants. Weight was measured
in kilograms (kg) using a scale accurate to 5 grams (Scaletronix, White Plains, NY,
USA). Infant recumbent length, was assessed using an infant length board (Holtain
Limited, Crymuch, UK) accurate to 0.1 cm and head circumference was measured
using a non-stretchable measuring tape accurate to 0.1 cm (McCOY Health Science
Supply, Maryland Heights, MO, USA). Measurements were obtained in triplicate, the
calculated mean was used in analysis. Birth weight was extracted from the transfer
records accompanying the infant to CHOP and by parental report for the control group.
All measurements were converted to z-scores using World Health Organization (WHO)
standards.26
Resting Energy Expenditure
REE was measured in the CTRC by open-circuit indirect calorimetry using a
canopy based computerized metabolic cart (Sensor Medic 2900 Z; Sensor Medics,
Yorba Linda, CA, USA) in a thermal-neutral, noise-restricted environment.
Measurements were performed during a minimum 30 minute period of infant sleep
following an ad libitum feeding of breast milk or the infant’s usual formula given within
one hour of the start of REE measurement. Infants who were device fed did not have
feeds infusing during REE measurement. In infants, sleeping energy expenditure is
used as a proxy for REE due to the practical considerations of measuring energy
expenditure.27-29 The metabolic cart measures infant respiratory gas exchange of
oxygen consumption (VO2) and carbon dioxide production (VCO2) in 1-minute intervals.
The initial period of infant adjustment and any period of significant movement that
altered REE were excluded from analysis. Studies with less than 15 minutes of usable
data were eliminated from analysis. The remaining data points were averaged and the
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modified Weir equation30 was used to calculate the REE. The results of the measured
REE are expressed as kcal/day, and as a percent of the predicted values using
Schofield (%Sch)31 and WHO (%WHO)32 equations. The Schofield equation adjusts for
age, gender, weight and length, while the WHO equation adjusts for age, gender and
weight.
Body composition
Body composition was measured using the Total Body Electrical Conductivity
(TOBEC) instrument (TOBEC; model HP- Pediatric, 2 EM-SCAN, Springfield, IL), 33,34
TOBEC is based on a two-compartment model consisting of fat mass (FM) and fat free
mass (FFM). Infants were swaddled in a blanket to restrict movement with extremities
extended and held parallel to the trunk of the body. The swaddled infant was then
placed supine on the TOBEC sled. A minimum of five measurements were performed,
the mean FFM and FM in kg and % body fat are reported.
Statistical Analysis
Statistical analysis was performed using SAS V9.2 (SAS Institute, Cary, NC).
Infants with CHD were analyzed by SV and BV physiology classification to identify
differences between the groups. In addition, the SV and BV physiology groups were
compared separately to the healthy infants. Distribution plots were used to assess
normality of all variables. Chi-square was used to test the association between the
categorical variables. Descriptive statistics of the means, standard deviations, and
minimum and maximum values for the continuous variables and computation of
frequencies and percentages for categorical variables were calculated. Statistical
significance was determined at the p<0.05 level. Two sided t-tests were used to
compare mean differences in variables between the healthy and combined CHD
physiology group and between each of the CHD physiology groups and healthy infants.
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In addition, the mean difference between the SV and BV CHD physiology groups were
compared using ANOVA. Possible linear relationships between all continuous
variables were examined using Pearson’s correlation coefficient. Additionally,
Pearson’s correlations were used to explore linear relationships between the
continuous variables and REE kcal/day, and to determine the independent variables to
be included in a model to predict REE kcal/day. Due to high correlation among many
of the independent variables, the number of covariates in the regression model was
restricted to minimize multicollinearity. ANCOVA models were constructed to examine
the differences in REE kcal/day for each CHD physiology group and among healthy
infants while controlling for particular continuous covariates. The least squares means
and the difference of the means were used to evaluate differences among the healthy
and the CHD physiology groups. The variance of inflation factor, a measure of the
degree of multicollinearity present in the model was used to assess collinearity among
the independent variables.35 All models tested had a variance of inflation factor <10,
indicating multicollinearity was minimal in the models constructed.
Results
The study group included 93 infants with REE and TOBEC measurements. Of
the44 infants with CHD, 17 (18%) had SV physiology and27 (29%) had BV physiology.
There were 49 (53%) healthy infants in the control group. The distribution of cardiac
primary diagnoses is presented in Table 1. Characteristics of the study sample are
presented in Table 2, and were similar between the control group, and the SV and BV
groups. Mean age was similar between the groups at the 3-month visit (Table 3).
Weight, length, head circumference (Table 3, Figure 1), and WHO z-score means were
all significantly lower (p<0.05) in both the SV and BV physiology groups when
compared to healthy infants, with the exception of length z-score of the BV physiology
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group versus healthy infants (p=0.06). The SV and BV physiology groups only differed
in head circumference z-score; infants with SV physiology had smaller head size
(p=0.03).
The individual group means for REE kcal/day, %WHO REE, %Sch REE, FFM,
FM, and % fat are shown in Table 3. Compared to healthy infants (27%), infants with
SV (23.7%; p=0.04) or BV (22.7%; p<0.001) physiology had significantly lower % fat.
REE as %WHO predicted was significantly higher in infants with CHD than in healthy
infants (115, p=0.02). REE as %Sch predicted was higher in the BV group versus
healthy infants (112, p=0.02) but not in the SV versus healthy group. There were no
differences in REE or body composition between the SV and BV physiology groups.
From Pearson correlation analysis, REE kcal/day was significantly and
positively correlated with FFM (r=0.71, p<0.0001), FM (r=0.44, p<0.0001) and age in
days (r=0.31, p=0.003). From the multiple linear regression models, the best
predictors of REE kcal/day were FFM and infant age in days. The model that best
predicts REE kcal/day in this study sample includes FFM, age in days, and SV and BV
physiology and has an adjusted r2 =0.55 (Table 4). After adjusting for FFM and age in
days, the differences in REE kcal/day between infants with either SV or BV physiology
and healthy infants (reference group) were not significant. A model including FFM, FM,
age in days and physiology was examined; however, FM was not significant in the
presence of the other variables and did not contribute to the prediction of REE kcal/day
for infants with CHD.
Age was a significant covariate in each model tested. When age was removed,
retaining FFM, and SV and BV physiology, there was a decrease in variance from
r2=0.55 to r2=0.53 for predictors of REE kcal/day. An interaction term for SV and BV
physiology and FFM was tested but was not statistically significant, nor did these
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interactions contribute to the prediction of REE kcal/day (data not shown). REE
kcal/day increased significantly with increasing FFM (kg) in this study sample, with no
significant difference found in the slope of this increase among the three groups
(healthy, SV, and BV).
Discussion
In this study, we evaluated REE at 3 months of age in infants who underwent
neonatal surgery for CHD compared to healthy infants. After adjusting for FFM and
infant age in days, there was no difference in REE kcal in infants with SV or BV
physiology compared to healthy controls. These findings do not support the clinically
held hypothesis that post-operative cardiac physiology is a primary factor causing an
increased REE kcal/day, contributing to delayed growth in infants with CHD. Instead,
these data demonstrate that body composition; specifically FFM and infant age were
strong predictors of REE kcal/day in our study sample.
As expected, the strongest and most consistent contributor to REE kcal in this
study was FFM. As the metabolically active component of body composition,
consisting of organs, muscles, skin, brain, bone, and supporting tissues, FFM is the
major contributor to REE kcal.36-38 An increased amount of FFM leads to an increased
REE per kg of body weight. The development of FFM during fetal life and early infancy
is environmentally regulated and is contingent on nutrient intake.39 In our study sample,
there was no difference in the mean FFM between the study groups. Despite its strong
positive correlation (r=0.44, p=<0.0001) to REE kcal, total FM in kg, the most variable
constituent of body composition in infancy was also not significant between the groups,
nor did FM significantly contribute to the model predicting REE after adjusting for FFM
and age.
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The rapid weight gain, common in early infancy is due in large part to an
increase in FM, which does not contribute significantly to REE kcal, likely related to the
modest metabolic activity of fat tissue.36,40 Although total FM in kg did not differ
between groups, % body fat was significantly lower in infants with CHD when
compared to healthy infants. At birth, full term neonates have approximately 14 - 15%
body fat.36 Fat accretion progresses rapidly in early infancy, and by 3 months of age,
male infants have 25-30% body fat, and female infants have as much 32%. .36,41 This
rapid increase in the typically developing infant results from a positive energy balance,
or energy intake that exceeds energy expenditure. Our data show the infants with CHD
to be below the expected % fat gains for age. The decreased weight z-scores in the
infants with CHD are primarily due to reduced FM rather than FFM suggesting
inadequate energy intake continues after hospital discharge.14 Insufficient energy
intake to support a positive energy balance will lead to loss of FM and a decreased
percentage of body fat per kg of body weight. This in turn commits a larger portion of
the infant’s body mass to metabolically active tissue, FFM, resulting in an increase in
REE kcal. Since the accretion of FM is directly related to energy intake, inadequate
caloric and nutrient intake in these infants was likely responsible for a reduced
accretion of fat and the decrease in % body fat. Our data show the infants with CHD
physiology to be below the expected % fat gains for age. Previous work reported poor
weight gain at hospital discharge,6,7 and findings of the current study demonstrate that
poor weight gain persists between hospital discharge and 3 months of age. Modest
improvement in caloric intake in infants with CHD will likely improve growth since there
is no demonstrated burden of an excessive use of energy related to cardiac
physiology.
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Interestingly, we found infant age to be highly significant in the regression
model (p=0.0006). The wide age range in this study sample across all groups (71 –
140 days) may account for the significance of age in the model. In multiple models
tested, infant age was consistently a significant covariate. These findings are similar to
those of Puhakka et al19 who also found age to be a significant predictor of REE kcal,
in their cohort of 25 subjects with CHD whose ages ranged from 2-months to 10 years.
In the last two decades, we identified nine studies examining REE kcal in
infants with CHD.15-23 A review of these studies and others by Nydegger and Bines42
identified poor growth as a common occurrence in this patient population. Our study is
unique in its approach to understanding energy expenditure in infants with CHD
following neonatal surgical intervention. We compared a healthy control group to
infants with CHD who underwent surgical intervention in the neonatal period, body
composition was measured in all subjectsat 3 months of age, and all subjects with
CHD were in their usual state of health at the time of study measurement.
Current clinical recommendations of energy requirements for healthy infants at
3 months of age are approximately 95 kcal/kg/day across gender irrespective of
formula or human milk intake.43 This recommendation is to provide a positive energy
balance in an infant of appropriate size and body composition to support growth and
activity compatible with good health.44,45 Our data demonstrate statistically significant
differences in kg weight and weight z-score at 3 months of age in infants with CHD
compared to healthy infants, this difference is primarily due to reduced percent body
fat. This deficit suggests that a moderate increase in caloric intake supporting the
accretion of FM may increase the% body fat to meet energy requirements in infants
with CHD, thus improving growth and development and decreasing the potential risks
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of delayed neurobehavioral development, morbidity and mortality associated with poor
growth in infancy.45,46
Study Limitations
Study limitations included this being a single center cohort study our results
cannot be generalized. A major limitation of this study is lack of caloric and nutrient
intake data. Birth weight was obtained from the transfer record or from parent report
and are not as accurate or reliable as those obtained at 3 months of age in the
research setting. Lastly, there may be bias in that the families of infants who were
sicker did not return for testing.
Conclusion
Our findings refute the commonly held clinical view that postoperative cardiac
physiology is a major factor in determining the energy expenditure of infants with CHD
following neonatal surgical intervention. Infants with CHD had decreased weight zscores and percent body fat at 3 months, which is attributable to inadequate energy
intake and not post surgical cardiac physiology. These data suggest intermittent
measurements of body composition to accompany incremental growth measures may
provide better information on growth and have far-reaching implications for healthcare
providers to intercede in the nutritional support of those infants with CHD at risk for
growth failure.
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Table 1 Congenital Heart Disease diagnoses of study sample
Single-Ventricular

Bi-Ventricular

% of n = 17

% of n = 27

Hypoplastic Left Heart Syndrome

76

Double Outlet Right Ventricle

12

Tricuspid Atresia

6

Valvular Aortic Stenosis

6

D-Transposition of Great Arteries

33

Coarctation of the Aorta

22

Tetralogy of Fallot

19

Valvular Pulmonary Atresia

7

Total Anomalous Pulmonary Venous
Return

7

Interrupted Aortic Arch

4

Ventricular Septal Defect

4

Double Inlet Left Ventricle

4

Primary diagnoses with post-operative physiology classification, depicted in percent of
total subjects for each category.
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Table 2 Sample characteristics of healthy infants and infants with Congenital Heart
Disease.
Healthy
Infants

Infants with Congenital Heart Disease
All

Single
Ventricle

Bi-Ventricle

49

44

17

27

63
37

61
39

71
29

56
44

27

7

6

7

2

0

0

0

Caucasian

65

91

94

89

Other

6

2

0

4

6

9

6

11

Non Latin/Hispanic

88

68

82

59

Other

6

23

12

30

n
Gender (%)
Male
Female
Race (%)
African American
Asian

Ethnicity (%)
Latin/Hispanic

Birth Weight
kg

3.4 ± 0.5

3.4 ± 0.4

3.5 ± 0.3

3.3 ± 0.5

z-score

0.2 ± 1.0

0.2 ± 1.0

0.5 ± 0.6

0.0 ±1.0

Sample distribution for gender, race and ethnicity with birth weight.
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Table 3 Growth, body composition and resting energy expenditure in all subjects at 3
months of age. *
Healthy
Infants

Infants with Congenital Heart Disease
All

n
Age at visit, days

49
95 ± 13

44
96 ± 13

Single
Ventricle

Bi-Ventricle

17

27

99 ± 15

93 ± 11

Weight
kg

6.1 ± 0.8

5.6 ± 0.9 **

5.6 ± 1.0 **

5.5 ± 0.7 **

-0.3 ± 1.0

-1.1 ± 1.1 ***

-1.1 ± 1.1 **

-1.0 ± 1.0 **

61.4 ± 2.8

59.8 ± 2.3 **

60.1 ± 2.1

59.6 ± 2.5 *

-0.7 ± 1.1 *

-0.8 ± 0.9 *

-0.6 ± 1.2

40.8 ± 1.3

39.7 ± 1.5 ***

39.2 ± 1.6 ***

40.0 ± 1.3 **

z-score

0.3 ± 0.9

-0.6 ± 1.2 ***

-1.1 ± 1.3 ***

-0.2 ± 1.1 *§

Fat-free Mass, kg

4.4 ± 0.5

4.3 ± 0.5

4.2 ± 0.5

4.3 ± 0.5

Fat mass, kg

1.7 ± 0.5

1.3 ± 0.4

1.4 ± 0.5

1.3 ± 0.3

z-score
Length
cm
z-score

0.0 ± 1.2

Head
Circumference
cm

% Fat

27.0 ± 5.0

23.1 ± 5.1 **

23.7 ± 5.5 *

22.7 ± 4.9 **

REE Kcal/day

328 ± 52

324 ± 55

325 ± 59

322 ± 54

105 ± 13

112 ± 13 *

111 ± 14

112 ± 12 *

104 ± 13

115 ± 14 **

115 ± 17 *

114 ± 12 *

Schofield, %
predicted
WHO, %
predicted

*Results shown are means + SD. Significance levels *p<0.05, **p<0.01, ***p<0.001
show healthy infants compared separately to the combined and with each CHD
physiology group; §p<0.05 depicts significance comparing the SV and BV CHD groups.
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Table 4. Regression model of covariates with strongest contribution to REE kcal/day
Parameter

Standard Error

t value

p

r2

Intercept

-95.2

41.6

-2.3

0.02

0.55

FFM, kg

72.7

7.3

9.8

<0.0001

Age, days

1.6

0.3

3.6

0.0006

SV

7.6

10.3

0.7

0.5

BV

8.3

8.7

1.0

0.3

n = 93
Model depicting contribution of FFM, age and cardiac physiology to REE kcal/day.
Healthy infants are the reference group.
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Figure 1 Box plot graph of growth measures at 3 months of age.
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Legend:
N for each group: SV – 17, BV – 27, Healthy – 49.
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SV BV Healthy
Head Circumference

Figure 2 Regression line of REE kcal/day for fat-free mass (FFM), kg from TOBEC
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The predicted line is calculated from an ANCOVA model using REE kcal/day as the
dependent variable with FFM and physiology as independent variables.
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CHAPTER 3
The Use of Indirect Calorimetry (IC) to Measure Energy Needs in Mechanically
Ventilated Children with Acute Lung Injury
(Submitted as NIH Director’s Early Independence Award Application)
Abstract
Acute Lung Injury (ALI) is associated with significant morbidity and mortality in
critically ill children. Annually, between 2,500 and 9,000 children are diagnosed with
ALI, a condition of lung injury marked by diffuse pulmonary inflammation that leads to
hypoxemia and respiratory failure. Characterized by acute onset, severe arterial
hypoxemia, and diffuse bilateral pulmonary infiltrates, ALI can quickly progress,
requiring mechanical ventilation for respiratory support and inciting a metabolic stress
response. If not halted, these physiologic reactions to stress prolong healing and
increase the risk for complications. In a critical illness such as ALI, optimal nutrition
support is essential to diminish the metabolic response, support immune function,
promote tissue repair, prevent loss of lean muscle mass, and eliminate weight loss.
Current clinical practice uses prediction equations derived from measurements of
healthy children and adults. These equations tend to over- or underestimate energy
needs and risk over- or underfeeding, threatening clinical outcomes. We purport that
the use of Indirect Calorimetry (IC) to measure energy needs is superior to prediction
equations and in fact, can help improve current nutrition management for critically ill,
mechanically ventilated children with ALI. Our study will test the efficacy of using IC to
accurately measure energy needs to the current practice of prescribing caloric needs
based on the use of prediction equation calculations in critically ill, mechanically
ventilated children with ALI. We hypothesize that compared to the use of standard
prediction equations, energy requirements derived from IC measurements will improve
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clinical outcomes, measured by increase in ventilator-free days, decreased weight loss,
decreased loss of lean body mass, and decreased length of pediatric intensive care
admission with an overall reduction in the length of hospitalization.
Specific Aim
ALI is associated with significant morbidity and mortality in critically ill children.
Annually between 2500 and 9000 children are diagnosed with ALI,1 a condition of lung
injury marked by diffuse pulmonary inflammation that leads to hypoxemia and
respiratory failure.1-6 Characterized by acute onset, severe arterial hypoxemia, and
diffuse bilateral pulmonary infiltrates, ALI can quickly progress, requiring mechanical
ventilation for respiratory support and inciting a metabolic stress response.1 This
metabolic response uses endogenous energy stores to provide for basic metabolic
needs and support the ongoing stress response.7-10 If not halted, these physiologic
reactions prolong healing and increase the risk for complications. In a critical illness
such as ALI, optimal nutrition support is essential to diminish the metabolic response,
support immune function, promote tissue repair, prevent loss of lean muscle mass, and
eliminate weight loss.7,11 Research suggests that 16–20% and as high as 50% of
critically ill children demonstrate significant protein energy malnutrition (PEM) within 48
hours of admission, with continued deterioration during hospitalization.10-14 Current
clinical practice using prediction equations derived from measurements on healthy
children15,16 will likely over or underestimate energy needs, risking over or underfeeding
and threatening clinical outcomes.15 We propose the use of IC to measure energy
needs, which research suggests is superior to prediction equations to assess energy
requirements and improve current nutrition management for critically ill, mechanically
ventilated children with ALI. To improve clinical outcomes and decrease length of
hospital stay providing specific caloric goals are vital to counter the metabolic response
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to critical illness, increase ventilator-free days, minimize loss of lean muscle mass, and
diminish weight loss for critically ill, mechanically ventilated children with ALI.17
Innovation and Impact
The caloric needs of critically ill children with ALI are related to the energy
burden imposed by the metabolic response to the inflammatory process and the
severity of illness.7,18 We suggest that measurement of energy expenditure by IC will
prove to be an accurate method to assess energy needs of critically ill children with
ALI. Current practice, the use of standard prediction equations with or without a stress
factor, are likely to over or underestimate energy requirements in critical illness,14,19-23
with the potential to prolong mechanical ventilation, increase the risk of infection, and
extend hospitalization due to prolonged recovery.24 To date, we are not aware of
clinical investigation assessing energy requirements for a specific disease in critically
ill, mechanically ventilated children in an intensive care unit. This study may reveal
energy requirements not previously acknowledged by critical care providers for
critically ill children with ALI. Indirect Calorimetry can provide precise information about
energy needs for children with ALI to optimize nutrition support and minimize the
caloric imbalances often incurred from use of prediction equations. This approach to
energy needs assessment has high potential for clinical implementation and has the
capability to shift clinical practice paradigms of nutrition management in the Pediatric
Intensive Care Unit (PICU) environment. Our study will test the efficacy of IC in
critically ill, mechanically ventilated children with ALI to assess energy requirements
and inform prescription for caloric goals. IC will be assessed during the acute, plateau,
and weaning phase of mechanical ventilation. In contrast to prediction equations,
accurate measurement of energy expenditure can provide more precise information to
determine specific caloric needs, inform clinical practice and assist decision-making for
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nutrition support. This randomized, controlled clinical trial will compare IC
measurements to the current clinical practice, use of prediction equations to determine
energy needs, and examine outcomes specifically related to critical illness and
mechanical ventilation in children with ALI.
Primary Aim
To compare the effect of using Indirect Calorimetry to determine energy
requirements in critically ill, mechanically ventilated children with Acute Lung Injury to
the current clinical practice of prescribing energy needs by the use of prediction
equation calculations.
Hypothesis
Compared to the use of standard prediction equations, energy requirements
derived from Indirect Calorimetry measurements for critically ill, mechanically ventilated
children with Acute Lung Injury will improve clinical outcomes as evidenced by:
1) Increase in ventilator-free days
2) Decreased weight loss
3) Decreased loss of lean body mass
4) Decreased length of Pediatric Intensive Care Unit hospitalization
Background and Significance
Acute Lung Injury
Acute lung injury (ALI) is a condition marked by diffuse pulmonary inflammation that
leads to hypoxemia and respiratory failure in both children and adults.1-6 It is associated
with high mortality, morbidity, and an increased use of intensive care resources with
significant financial burden.1-3 Characterized by acute onset, severe arterial hypoxemia
resistant to oxygen therapy, and diffuse bilateral pulmonary infiltrates without evidence
of left atrial hypertension, ALI has a variety of triggers and risk factors, the most
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common being infection in the pulmonary airways and parenchyma.1,25 In the United
States, between 2,500 and 9,000 children are diagnosed with ALI annually, constituting
between 1– 4% of all Pediatric Intensive Care Unit (PICU) admissions.1,26 The high
volume of children with ALI, severity of the disease, and potential for increased
morbidity make this a suitable illness to investigate energy needs for a subgroup of
critically ill children requiring mechanical ventilation. Approximately 63% of children
have more than one risk factor for developing ALI, a rate similar to that found in
adults.25 These factors include direct lung injury (51% pulmonary infection, 12%
pulmonary aspiration, 3% near drowning) and indirect lung injury (43% sepsis
syndrome, 40% multiple transfusions in close proximity, 10% post-bone-marrow
transplantation, 8% non-thoracic trauma). Mortality associated with ALI is reported to
be as high as 18–35% in children.5 Due to the severity of the pulmonary disease,
children with ALI often quickly progress to respiratory failure requiring endotracheal
intubation and mechanical ventilation. The disease process and respiratory failure
activate an acute alteration in metabolic status and trigger initiation of the stress
response and the ensuing catabolism inherent in the process. Characteristics of the
disease, the ensuing respiratory failure requiring mechanical ventilation, the metabolic
stress response, and decreased energy intake put these children at risk for alterations
in energy balance, PEM and its consequences leading to a prolonged PICU stay and
extended hospitalization.1,4 Despite its frequency as a diagnosis in the PICU population
and its severity, we have not found an investigation specifically designed to assess the
energy needs of critically ill, mechanically ventilated children with ALI. The severity of
illness, metabolic response to lung injury, alterations in caloric requirements, and
decreased energy intake are dynamic factors that potentially make the use of standard
prediction equations inconsistent with actual energy needs; the use of IC is a more
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accurate method to assess energy needs and prescribe appropriate caloric intake. It
follows that children with ALI requiring mechanical ventilation and supportive care will
benefit from early, accurate assessment of energy needs and nutrient prescription for
appropriate caloric goals to decrease the harmful effects of catabolism resulting from
the metabolic response to critical illness.
Metabolic Alterations in Critical Illness
Metabolic alterations that accompany critical illness occur in proportion to the
magnitude of the illness and the pre-illness nutrition status. It is not always possible to
predict the child’s response to illness owing to the range of illness onset, its intensity,
and its duration. The metabolic response to critical illness is variable, and includes
hormonal and cytokine profiles that influence the overall energy burden.7,10,27
Characterized by an elevation of serum hormone levels of insulin, glucagon, growth
hormone, and cortisol and combined with the release of catecholamines and cytokines,
the stress response results in catabolism of endogenous supplies of protein, fat, and
carbohydrates. This process provides energy for both basal metabolism and the
metabolic requirements incited by the presenting illness.10 Typically, the metabolic
response to stress induces muscle protein breakdown that results in increased
circulation of free amino acids, some of which are used for tissue repair. Those free
amino acids not used in repair are redirected through the liver and become involved in
the production of glucose through gluconeogenesis. The increase in circulating serum
glucagon levels may deplete the limited endogenous stores, increasing reliance on
gluconeogenesis from non carbohydrate substrates (e.g. lactate).10,27 In addition,
cytokines mediate fat metabolism, causing increased fatty acid oxidation, resulting in
hypertriglyceridemia and lipid intolerance. Ketone production results from lipolysis to
provide energy and protection for the brain to maintain its uninterrupted and large
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supply of glucose.27 It is common for children to have a delayed response to nutrition
support, this predisposes them to develop malnutrition from the metabolic response to
stress faster than adults.8 The administration of exogenous substrate of glucose does
not stop gluconeogenesis, and alteration in carbohydrate metabolism continues;27
however, the combined provision of glucose and protein may blunt the process by
supporting protein synthesis.7 The ability to utilize exogenous energy substrate and
synthesize new proteins is a critical aspect of recovery from critical illness and
resumption of normal metabolic processes. The capability to accurately assess caloric
needs and prescribe appropriate energy goals may facilitate early protein synthesis.
Given these alterations in the metabolic process with critical illness, and the severity of
illness seen in children with ALI requiring mechanical ventilation, it is conceivable that
PEM would complicate the disease process, delay recovery, and increase the length of
hospitalization.15 Overall, the metabolic response in ALI results in increased protein
breakdown and lipid and glucose intolerance. This combination of reactions, along with
suboptimal nutrition support, puts the critically ill child at high risk for weight loss, loss
of lean body mass, and an exacerbation of malnutrition that can worsen disease
progression.10,27
Suboptimal Nutrition Support in Pediatric Critical Illness
Nutrition support during critical illness such as ALI is challenging. The potential
risk of malnutrition and caloric imbalance can lead to PEM, which is associated with
altered physiologic response(s), impaired cell-mediated immunity, and loss of lean
body mass.9,22 Acute PEM in critical illness is multifactorial, owing to the dynamic range
of metabolic alterations, the child’s age, and severity of illness.7,12,28 It is difficult to
determine if the degree of illness contributes to a poor nutrition status or if a poor
nutrition status contributes to the severity of illness. The metabolic response to critical
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illness cannot be prevented solely by nutrition support; however, suboptimal nutrition
accompanied by critical illness may contribute to prolonged alterations in metabolism
and exacerbate the stress response.
The effects of PEM in critically ill children were noted over two decades ago by
Pollack et al,29 who demonstrated acute PEM in 16% of their heterogeneous sample of
50 children admitted to the PICU; the condition was associated with clinical instability,
increased use of PICU resources, and higher rates of mortality. More recently, Hulst
and colleagues30 demonstrated a cumulative energy deficit of 100 kcal/kg and a
cumulative protein deficit of 10 gm/kg, which explained 39% and 40% of the respective
change in kilogram weight and lean body mass in their cohort of 98 mechanically
ventilated children. Despite advances in clinical care, the challenges of nutrition
support for children during critical illness identified in the 1980s persist.7-9,29,31,32
The lack of recognition and knowledge by care providers to the unique and
complex energy needs of the critically ill child add to the challenges of providing
adequate caloric intake during critical illness.7,29 In a recent study of 33 PICU subjects
with various diagnoses, Mehta and colleagues15 demonstrated failure of physicians to
accurately predict the metabolic status of the children studied, supporting the idea that
providers are unaware of metabolic requirements in critical illness. The researchers
deduced this was a contributing factor to overestimation of energy needs and
subsequent overfeeding in their study sample.15 This lack of accuracy in energy
assessment puts critically ill children such as those with ALI at risk for overfeeding or
underfeeding, either of which can contribute to acute PEM and potentiate infectious
and non-infectious complications, alterations in normal physiologic response to illness,
additional use of PICU resources, increased financial burden and can add to morbidity
and mortality.7,12,13,15,33,34
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Lack of energy intake or underfeeding has been associated with gastrointestinal
mucosal atrophy, heightening the subject’s susceptibility to infection, delayed wound
healing, muscle weakness prolonging the need for mechanical ventilation, diminished
cardiac reserve, and immune system dysfunction.7,9,12,14,33,35,36 Alternatively,
overfeeding can result in increased carbon dioxide production prolonging mechanical
ventilation, alteration in hepatic function, and variation in glycemic control.7,8,12,17,33,36
Either condition can be potentially life threatening for the mechanically ventilated child
with ALI who has a compromised respiratory status. Studies suggest that critically ill
children who receive adequate nutrition support experience early physiologic stability
and improved outcomes.8,35 The American Society for Parenteral and Enteral Nutrition
(A.S.P.E.N.) acknowledges that investigations specific to critically ill children are
necessary to guide nutrition support.18,22 Recently published guidelines for nutrition
support in critically ill children concede the inaccuracy of predictive equations to
estimate energy needs and suggest further investigation on the use of IC as a method
to accurately assess energy expenditure and guide energy prescription for critically ill
children.15,22
Determining Energy Needs: Predictive Equations and Indirect Calorimetry
Energy requirements in children are derived from standard prediction
equations. The equations frequently used in pediatrics include those developed by
Harris-Benedict, Talbot, Schofield, the Food and Agriculture Organization/World Health
Organization/United Nations University (FAO/WHO/UNU), and the Recommended
Dietary Allowance (RDA) predictions.6,17,37,38 The Harris-Benedict equation was based
on measurements in 97 infants under one month of age and more than 200
adolescents.20,39 Talbot developed energy estimates from data obtained through
repeated measures on healthy infants and children (the same participants) combined
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with previously published studies.40 Schofield refined the initial predictive equations,
including those developed by Talbot, and constructed equations using weight, height,
and gender across age groups.41-43 The RDA is an estimate of the minimum average
daily intake necessary to meet nutrient requirements of healthy individuals across
gender and age.38
Studies conducted in heterogeneous PICU populations have shown
incongruence between measured energy expenditure and prediction equations.
Thomson et al44 demonstrated inaccuracies between the Harris-Benedict and Schofield
equations when compared to measured energy expenditure in both healthy and ill
infants. Coss-Bu et al45 found large differences between the Harris-Benedict and Talbot
equations, with and without use of a correction stress factor, when compared to IC
measurements in critically ill, mechanically ventilated children. Briassoulis and
colleagues17 found energy expenditure measured by IC to be significantly lower than
energy expenditure derived from prediction equations. Other researchers have found
under and overestimation of energy needs when using prediction equations and
endorse the use of IC to accurately assess energy needs and prescribe realistic caloric
intake goals for critically ill children.1,9,19,23,24,33,46,47 Many of the studies cited do not
address assessment of body composition as part of IC measurement. However,
determination of body composition is necessary for the judicious interpretation of
prediction equations and IC measurement. It is the variation in fat-free mass that may
explain a large component of energy needs, in that energy expenditure may be
decreased in children with a higher percentage of fat-free mass per kilogram of body
weight.48 The respiratory quotient (RQ) is another important marker obtained from IC
measurement. The RQ thought to be indicative of substrate use is a ratio derived from
carbon dioxide production (VCO2) to oxygen consumption (VO2) with an acceptable
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range of 0.85 to 1.0 in children. Used to substantiate the validity of IC measurements,
an RQ above 1.0 may indicate overfeeding, while less than 0.85 may be a sign of
suboptimal energy intake. Applicability of the RQ in critical illness is limited owing to
alterations in metabolism, a compromised respiratory status, and its reported low
sensitivity and specificity in both adults and children.28,49 De Klerk et al35 found the RQ
in mechanically ventilated, critically ill children to indicate underfeeding in 45% of their
study sample and overfeeding in 15%. These researchers suggest RQ measurements
combined with IC measurements may be a better approach to assessment of energy
needs in critically ill children.35
Current Practice for Derived Energy Requirements
Investigations into energy requirements in critically ill children overwhelmingly
suggest inaccuracy of prediction equations to estimate energy needs.17,22-24,33,46,47,50 In
a recent study by Mehta and colleagues19 there was poor agreement between
equation derived energy needs and IC measured energy expenditure, resulting in a
high incidence of overfeeding and underfeeding, in their study sample, based on the
equations alone. Challenges with the use of these equations lie in the fact that they are
based on demographics from healthy children under conditions of usual environment
and physical activity16 and they do not account for the shifts in energy requirements
that accompany critical illness. Energy normally used for tissue accretion and growth is
used for tissue repair and glucose generation in critical illness; there is minimal
physical activity; and there is a transient cessation of growth during critical illness that
alters energy requirements.7,16,17,30 The metabolic response that is proportional to the
severity of illness can trigger changes in energy metabolism that work to counteract the
stress response while simultaneously lending support to basal metabolic function7;
prediction equations cannot adjust for these changes. This is particularly true for
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critically ill children with ALI whose energy needs may be significantly altered, and in
whom inaccurate assessment of needs may lead to overfeeding or underfeeding and
affect an already compromised metabolic and respiratory status. In the PICU at The
Children’s Hospital of Philadelphia (CHOP), energy requirements are derived by
prediction equations. Dedicated PICU nutritionists primarily use the RDA for children
less than 1 year of age and the World Health Organization (WHO) equation for children
over 1 year. If the child is overweight and a length or height measurement is available
the Schofield equation is applied, lastly, in the case of an older adolescent or young
adult the Harris-Benedict equation is used to calculate energy requirements (personal
communication: M. Nagel RD, LDN, CNSD, S. Seiple, RD, LDN, CNSD; January 12,
2011). Based on calculations derived by one of the aforementioned equations,
prescriptions for caloric intake are generated. The child’s progress is followed and
adjustments for energy needs are made based on clinical status, laboratory results,
and respiratory progress. The decision to increase calories by use of a stress factor is
made by the clinical nutritionist in discussion with the critical care team based on age,
history,and severity of illness. Using IC to determine specific energy requirements and
prescribing such for critically ill, mechanically ventilated children with ALI can achieve
optimal nutrition support and avoid caloric imbalances often incurred with the use of
prediction equations.
Research Design and Methods
Study Overview
This study is a two-group randomized, controlled clinical trial that compares
energy requirements derived from IC measurement of energy expenditure to the
current practice of energy requirements derived from standard prediction equations.
After obtaining informed consent, subjects diagnosed with ALI will be randomized to
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either the study or control group. The study group will receive IC measurements in
addition to prediction equation calculation for energy requirements, versus the control
group who will maintain the current practice of sole use of prediction equation
calculations to derive energy needs. Prediction equations, as described above, will be
calculated for all study participants to evaluate differences between IC measured
energy needs and energy needs derived from prediction equations. Those participants
who receive IC measurements will have their prescription for energy intake based on
the IC measurement and will receive caloric intake based on this measurement for the
duration of the study period. Participants whose energy needs are assessed by
prediction equation will have energy intake prescriptions generated accordingly. All
intake will be recorded and assessed daily for caloric content and total fluid volume for
each child participating in the study. This will include all intravenous fluids, glucose
containing base solutions for medications (enteral or intravenous), and enteral or
parenteral nutrition. All participants will have anthropometric measurements of weight,
supine length, and head circumference (if 5 years of age or younger). In addition, 4
skinfold measures including subscapular, tricep, bicep, suprailiac, and a mid upperarm
circumference will complete the anthropometric data set. These measurements will be
obtained upon study enrollment, prior to each IC measurement and at PICU discharge
or day 28 of study participation, whichever occurs first. Study participation will end at
28 days regardless of whether the participant remains mechanically ventilated or
remains in the PICU. The Acute Respiratory Distress Syndrome network defines
ventilator-free days (VFD) as the number of days from study enrollment to day 28
during which there is unassisted spontaneous breathing for 48 consecutive hours.51 All
participants will receive usual PICU care for ventilator and supportive management.
Usual PICU care includes extubation readiness testing (see appendix).
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Figure 1 Randomization Schema

Eligibility and Recruitment
Study Setting
The sample will be drawn from children admitted to the PICU at CHOP. This is
an internationally recognized clinical, critical care research center with a 54-bed
multidisciplinary intensive care unit that admits more than 3,000 critically ill children
annually. Age of children admitted to the PICU ranges from neonatal (28 days) to 18
years. The RESTORE clinical trial (U01HL086622; U01HL086649; Principal
Investigator: Martha A. Q. Curley, RN, PhD) is currently recruiting intubated and
ventilated participants with acute respiratory failure from the PICU at CHOP. In the
most recent 18 months, 108 participants consented and enrolled, 37% of whom had a
diagnosis of ALI. These data support the feasibility of recruitment for the current
proposal.
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Study Sample
Children admitted to the PICU and diagnosed with ALI will be screened for
study eligibility and participation. Parents or legal guardians will be approached for
consent if their child meets study criteria. All participants will be children with a
diagnosis of ALI requiring mechanical ventilation, who are at least 44 weeks post
conceptual age but have not yet reached their 19th birthday. Given that all participants
will be intubated and mechanically ventilated, it is anticipated that subjects will not be
able to provide assent to participate in the study. The exclusion criteria are designed to
eliminate potential participants with conditions known to alter basal metabolism and/or
conditions that can lead to inaccurate IC measurement results. Study exclusion criteria
include infants less than 44 weeks post conceptual age owing to typical physiologic
changes of the premature newborn that require increased energy, children with chronic
pulmonary disease and those with known chromosomal abnormalities. In addition,
children with illnesses that result in a compromised respiratory or pulmonary status
known to have alterations in energy requirements at baseline or the presence of air
leak through chest tube(s) causing inaccurate IC measurements are ineligible for
enrollment.52 Table 1 specifies inclusion and exclusion criteria.
Randomization
Once informed consent is obtained, study participants will be randomized at
enrollment to receive IC measurements in addition to having energy needs calculated
with prediction equations (intervention group) versus current practice for use of
prediction equations alone. Randomization will be performed using a permuted block
design with random block sizes53 to ensure an equal allocation of participants to both
the intervention and control groups throughout the study. Allocation will be concealed
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using serially numbered, opaque sealed envelopes containing study assignments. The
randomization schema is presented in Figure 1.

Table 1 Inclusion and Exclusion Criteria
Inclusion Criteria

•

•

•

Exclusion Criteria

At least 44 weeks
postconceptual age but have
not yet had their 19th birthday

•

Diagnosis of acute lung injury:
Intubated and mechanically
ventilated with a ratio of partial
pressure of arterial
oxygen((PaO2) to the fraction
of inspired oxygen (FIO2) of
300), bilateral pulmonary
infiltrates, and no clinical
evidence of left atrial
hypertension

•
•

•

•
•

•

Intubated with a cuffed or
uncuffed entdotracheal tube
with negligible air leak ≤ 5%
difference between inspired
and expired tidal volumes

•
•
•
•
•
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Chromosomal abnormalities
(known or suspected)
Metabolic disorders (known or
suspected)
Congenital heart disease
Severe brain injury
(Glasgow coma scale <8)
Presence of chest tube(s) with air
leak
Supported on extracorporeal
membrane oxygenation (ECMO)
or High Frequency Oscillatory
Ventilation (HFOV)
History of/presence of oxygen
and/or diuretic dependent chronic
lung disease
Upper airway diseases
(e.g. bronchial / tracheomalacia,
Neuromuscular respiratory failure
(e.g. spinal muscular atrophy)
Chronic ventilator dependence
Agreement that continued
treatment is futile
Concurrent participation in any
other clinical trial

Power Analysis
Based on preliminary data, we estimate the overall median numbers of
ventilator-free days (VFD) in the control group to be 21, recognizing that these data are
skewed consequential to assigning zero VFD to participants censored at the end of
their stay. As such, group sample sizes of 50 each will achieve 80% power to detect a
difference of 3 days between the groups (21 verses 24 VFD). The estimated group
standard deviations are assumed to be 4.0, along with a significance level (alpha) of
0.01 to account for multiple outcomes. This calculation is based on a two-sided MannWhitney U test.
Attrition
Although attrition is expected to be minimal in this study, we will enroll 10
additional participants in each group to accommodate for participant dropout. Some
parents may opt to withdraw their child from the study. In addition, some participants
may improve rapidly and not provide 3 data points while other participants may
become too ill for 3 data points, or may not be able to tolerate the recommended
calories prescribed from IC measurement. Data will be analyzed with an intention-totreat analysis. Based on these assumptions, a completed data point is defined as one
completed IC assessment, with anthropometric measures and participant capability to
tolerate the caloric load recommended by the IC measurement. Nutrition support can
be delivered via either the enteral or the parenteral route; either route may be used for
the IC recommended caloric load to meet study completion criteria.
Study Procedures
The following section includes a discussion of the research protocol for the
proposed study. The major variables, their measurement, and the data analysis plan
are presented. Study measurements are outlined in Table 2.
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Participant PICU Measurements
Measurements of weight, length, and head circumference are obtained by the
Principal Investigator (PI) and /or Research Assistant (RA), the results will be shared
with the clinical staff. Weight measured in kilograms will be obtained on all potential
participants on admission to PICU in weigh bed scales (Stryker Medical, Portage, MI)
or infant weigh cribs (Hard Manufacturing Company, Buffalo, NY). If not admitted to a
weigh bed or crib, a weight will be obtained on the appropriate infant pan scale
(Scaletronix, White Plains, NY) or sling scale (Scaletronix, White Plains, NY) for age
and size. Head circumference is measured on subjects 5 years of age or less (protocol
of CHOP Nutrition and Growth Lab) using a non stretch, fiberglass tape measure.
Three measures are taken repositioning the tape between each measure; the mean of
the measures is recorded and used in analysis. Supine recumbent heel-to-crown
length will be measured on all subjects using flexible, non stretch measuring tape and
a stabilization board at the foot to optimize measurement.
Anthropometric Measures
Body composition, total fat-free mass, fat mass, and percent body fat will be
assessed by 4 skinfolds and a mid upper-arm and mid calf circumference using
prediction equations adapted for children and adolescents.54,55 All anthropometric
techniques will follow those described by Lohman et al56 and be performed by a trained
research anthropometrist. Anthropometric measurements will be assessed prior to or
following each IC measurement. Skinfold thickness to 0.1 mm will be measured at the
subscapular, tricep, bicep, and suprailiac sites with a skinfold caliper (Holtain,
Crymych, UK) to assess subcutaneous fat stores. Mid upper-arm and mid-calf
circumference will be measured with a non-stretch fiberglass tape to 0.1 cm (McCoy,
Maryland Heights, MO). All measurements will be taken and recorded in triplicate with
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the mean used in analysis. Lange and Holtain skinfold calipers, sliding calipers,
abdominal caliper, and anthropometer, and a knee-height measuring device for
assessment of short-term growth are used for measurements. Anthropometric
equipment is checked and calibrated before every assessment to assure proper
operation.
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Table 2 Study Measurements
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Prediction Equation Calculation
The PI and the clinical nutritionist will calculate energy needs based on an
appropriate equation for the participant’s age, gender, weight, stature and clinical
status. The Schofield,41 WHO,57 and RDA58 equations are used most often in our PICU
at CHOP and will be used for this study Parameters to use in the calculations are
specified by the equation.
Fluid and Nutrient Intake
All nutritional and non-nutritional intake will be retrieved from the clinical flow
sheet as documented by the bedside nurse and recorded daily for each enrolled
participant. Caloric and fluid intake and fluid balance will be followed daily for the 28day study period. Prescriptions for nutrient intake based on the recommendations of
the clinical nutritionist and prescribed by the provider clinically responsible will be
checked in the electronic medical record order system and documented by the RA in
the study clinical database. With few exceptions, nutrition support can be delivered to
critically ill children by either the enteral or the parenteral route or both. The enteral
route is preferred as it is the most physiologic, allowing stomach and bowel digestion
and absorption of nutrients. In the critically ill child, however, enteral intake may not be
possible for various reasons. Following IC measurements, the clinical nutritionist will
reassess the initially prescribed intake and make adjustments as indicated for
participants in the study group. The adjusted recommendations for energy intake made
in accordance with the IC measurements
will be communicated to the responsible prescriber and prescription changes made
accordingly. All energy intake inclusive of changes will be recorded daily for all
participants.
Indirect Calorimetry Measurement
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Using IC, resting energy expenditure (REE) and the respiratory quotient (RQ)
will be assessed during the participant’s acute phase, plateau phase, and weaning to
extubation phase of illness. Individual time points allow the intervention to be driven by
the participant’s clinical status. In the acute phase of ALI, which commences with the
onset of respiratory insufficiency, measured by an increasing ratio of the partial
pressure of arterial oxygen to the fraction of inspired oxygen (PF ratio), equal to 300
mmHg or less and requires ventilator support, is when alterations in metabolism may
be heightened. During this time, accurate assessment of energy requirements is
necessary to provide adequate calories to minimize loss of lean body mass and
minimize the catabolic effects that can occur with the metabolic stress response.
During the plateau phase, when ventilator settings have not escalated in the previous
24 hours, metabolic requirements may change and adjustment of caloric goals will
minimize the potential to over- or underfeed. At the point of weaning ventilator support
(the weaning phase) characterized by a progressive reduction in ventilator settings in
the preceding 24 hours, energy needs may again change, and an adjustment in
calories may be necessary.59
IC measurements will be obtained using a portable computerized metabolic cart
(Vmax SPECTRA (29s), Viasys Healthcare/Sensormedics, Yorba Linda, CA). The PI, a
pediatric critical care nurse practitioner, or a critical care trained physician will assess
the participant for hemodynamic and respiratory stability prior to initiation of IC
measurements. For the purposes of this study, respiratory stability is defined as no
escalation in ventilation within 4 hours of IC measurement, no ventilation changes
within 1 hour prior to IC measurement, acceptable oxygen saturation and end tidal
carbon dioxide levels (based on preceding 4-hour trend), equal bilateral breath sounds
with equal aeration and chest rise, absence of retractions, and no overt signs of
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respiratory distress (cough, excessive movement, pain, etc). Participants will be
assessed for a leak in the ventilator circuit that is 5% or less between measured
inspiratory and expiratory tidal volumes. Pain will be assessed by the PI using the
Faces, Legs, Activity, Cry and Consolability (FLACC) scale,60 cross-checked with the
bedside critical care nurse and both scores recorded. A score of 0–3 indicating none to
mild pain is necessary for the IC measurement to commence. If the FLACC scale score
is 3 or greater, the IC measurement will be postponed until the participant is in a
resting, comfortable state.
A registered respiratory therapist (RRT) trained in the care of critically ill,
mechanically ventilated children at CHOP will be present for the duration of each IC
measurement. In mechanically ventilated participants, an adapter is used to attach the
flow sensor of the metabolic cart to the exhalation outlet of the ventilator. This adapter
will be secured by the RRT and the participant will be reassessed for continued stability
and any changes in respiratory or ventilation status. Anticipating the possibility of lung
volume loss with attachment of the adapter, usual PICU procedures for managing lung
volume loss will be instituted and followed. For the entirety of each IC measurement on
each participant, a respiratory therapist, a critical care nurse specially trained in the
care of critically ill children requiring mechanical ventilation, the PI, and/or a criticalcare-trained physician will be in attendance. Should the participant exhibit any sign of
distress or clinical instability during IC measurement, the assessment will be
immediately aborted. Usual PICU care for safety will be maintained during IC
measurement, including but not limited to checking security and patency of the
endotracheal tube, continuous electronic hemodynamic monitoring and continuous
observed patient assessment. During each IC measurement, the environment will be
controlled in the usual manner as that used during an invasive or high-risk procedure in
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the PICU. Previous studies have not reported any serious adverse events associated
with IC measurements in mechanically ventilated children or adults.17,19,35,45,61
Following a well-established protocol from the Nutrition and Growth Laboratory
of Dr. Virginia Stallings at CHOP, an age-appropriate fast according to institution
standards will be instituted prior to each IC measurement. Every attempt will be made
to perform IC measurements between 6 a.m. and 10a.m. with the participant resting
and pain-free. Once the specified assessments are complete and the participant
determined clinically stable for IC testing, a 60-minute test will be performed. In
accordance with Dr Stallings’ protocol, 60 minutes is necessary to allow collection of an
adequate number of time points to ensure technical quality of the test, allow a period of
steady-state to commence, and have enough time measurements to assure quality
data collection for each IC measurement. Steady-state is defined as a period of time
after the start of the measurement with 10% or less variation in VO2 and VCO2 and a
5% or less variation in RQ measurements.62-64 Data from the first 10 minutes and
during periods of significant physical movement, coughing or agitation are eliminated,
with the remaining data averaged for the mean REE and RQ. REE is then
electronically calculated using the modified Weir equation and expressed in
kilocalories. REE from IC is then compared to values derived from prediction equation
calculations. The WHO equation adjusts for age, gender and weight,57 while Schofield
adjusts for age, gender, weight, and height.41 Fat-free mass will be assessed from
skinfold measures to determine its contribution to the REE.
Study Burden
We anticipate minimal study burden as all measurements are planned during
admission in the PICU. The degree of burden will be in a family’s decision to
participate. The study procedures will not interfere with any usual PICU care or
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procedures nor will it prevent participants transferring out of the intensive care unit
once they are clinically stable.
Study Safety
Safety of study procedures will be monitored for all study participants. There will
be strict adherence to study protocol with continuous electronic hemodynamic
monitoring in addition to continuous observation during the IC measurement by a
critical care provider (PI or critical-care-trained physician), critical care RRT, and the
critical care nurse. PICU precautions for maintenance of lung volume will include the
use of inline adapters and all usual maneuvers to minimize loss of lung volume when
the participant is disconnected from the ventilator circuit. Should a decrease in lung
volume occur, usual PICU maneuvers for re-recruitment will be employed. Participants
are monitored for respiratory and hemodynamic stability as well as environmental
safety throughout each IC measurement and throughout the study period.
Measurement of Study Outcomes
Study outcome is to compare the effect of using IC to determine energy
requirements in mechanically ventilated children with ALI to the current practice of
prescribing energy needs by the use of prediction equations. IC measurements as
proposed are useful for directing prescriptions for energy intake. This, we propose, will
result in:
1) Increase in ventilator-free days(VFD)
Ventilator-free days, is a composite outcome that reflects duration of mechanical
ventilation. For this investigation, VFD will be used to reflect appropriateness of energy
intake prescription. The numbers of consecutive days after the endotracheal tube has
been removed up to study day 28 constitute the absolute number of VFD. Removal of
the endotracheal tube will be calculated from the first time the tube is continuously
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absent for a minimum of 48 hours, with success defined as spontaneous breathing for
24 hours without support of mechanical ventilation.61 We expect to see a difference
between those nutrient prescriptions derived from IC measurements compared to
prescriptions derived from prediction equation calculations. The difference we propose
will manifest in a 20% increase in ventilator-free days in the study group compared to
the control group.
2) Decreased weight loss
Adequate caloric intake should minimize weight loss. There is an association between
cumulative energy deficit and decrease in weight-for-age z-score (0.06; 95% CI: 0.01 –
0.1).30 Participant weight is obtained on admission to the PICU and followed throughout
the study period. Although it is difficult to obtain weights during the course of acute,
critical illness, we will follow the trend and determine change from admission through
PICU discharge or study day 28, whichever occurs first.
3) Decreased loss of lean body mass
Appropriate energy intake should minimize loss of lean muscle mass. We expect that
sustained, appropriate intake will result in minimal breakdown of endogenous protein
stores. Hulst and colleagues30 demonstrate an association between cumulative energy
deficit and decrease in mid-upper arm circumference z-score (0.07; 95% CI: 0.009 –
0.1). We will follow anthropometric measurements to determine change in muscle
mass during the 28-day study period.
4) Decreased length of PICU hospitalization
With the use of IC to direct prescription for energy needs, participants should receive
appropriate intake during the PICU stay and experience a decrease in overall length of
hospitalization. Research has demonstrated that critically ill children who receive
appropriate nutrition support demonstrate increased physiologic stability and an earlier
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return to baseline health status, shortening the duration of the illness and decreasing
the length of hospitalization.35 We hypothesize that critically ill children with ALI
requiring mechanical ventilation who have energy needs assessed through the use of
IC and nutrient prescription based on IC data will demonstrate improved physiologic
status due to optimization of nutrition support, resulting in improved clinical outcomes
and decreased length of hospitalization in comparison to those children whose nutrition
was determined using standard prediction equations.
Overall Analysis Plan
Preparation of the Analysis Data Set
All primary and secondary outcomes will undergo 100% data audit against the
medical record. The data audit includes visual screening for missing data and
inconsistencies. All out-of-range values, inconsistencies, and missing data will
generate a query that will require examination of the participant’s medical record for
resolution. Preplanned construction of new variables will be conducted in accordance
with the study hypotheses and analysis plans. Variable transformation may be required
for interpretation and statistical analysis purposes.
Analysis Plan
The primary outcome for this study is the number of VFD in the two groups.
Secondary outcomes include a decreased loss of lean body mass (LBM) with weight
maintenance (baseline to day 28) and length of hospitalization. The median number of
VFD will be compared using the nonparametric Wilcoxon rank-sum (Mann-Whitney U)
test. Categorical demographic variables will be analyzed using the Chi-square test,
while differences in continuous demographic and secondary outcome variables (loss of
lean body mass and length of hospitalization) will be assessed with the two-sample
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Student t test (for normally distributed data) or the Wilcoxon rank-sum test (non-normal
data). Baseline analysis will include the following:
1. Comparison of the two groups using descriptive statistics (measures of central
tendency [means and medians] and dispersion [standard deviations and
interquartile ranges] for continuous variables with frequency counts and marginal
percentages for categorical variables) will be computed for all study variables and
examined for marked skewing, outliers, and any systematic missing data.
Transformations will be undertaken as required.
2. Pearson product intercorrelations will be computed and examined for
multicollinearity.
Statistical significance will be set at the 0.05 level based on the two-tailed alpha
test. Data analysis will be performed using SPSS (SPSS Inc., Chicago, IL) and
SAS (SAS Institute, Inc., Cary, NC) statistical programs.
Training of Study Personnel
In the start-up phase (first 9 months of study year 1), all members of the study
team will be trained on the study protocol. In addition, the PI will be trained and quality
tested for reliability on use of the metabolic cart to perform the REE measurements.
Both the PI and the RA will be trained and tested for reliability and reproducibility in
obtaining skinfold measurements, overseen by Dr. Stallings. Procedures for screening
of potential participants, family approach, and the consent and enrollment process will
be developed and evaluated for completeness with support from Drs. Medoff-Cooper,
Curley, and Srinivasan. The RA will be trained in participant screening, confirmation of
eligibility, family approach and consent, data abstraction, and data entry into a
password-secured database. RA activities will be directed and supervised by the PI.
Table 3 depicts the proposed training and study timeline.
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Table 3 Estimated Timeline of Study Activity
Year 1
Hire RA; Develop
databases, operations
manual, case report
forms; Complete IRB
process

Year 2

Year 3

Year 4

Year 5

1 2 3 4 1 2 3 4 1 2 3 4 1 2 3 4 1

2

3

4

PI, RA training
Participant screening,
enrollment, initiate
protocol, data collection,
data entry
Complete data entry, data
cleaning; Preliminary data
analysis

Final Data analysis
Dissemination of results

Responsible Conduct of Research
The PI has received and will continue to receive training on the ethical conduct
of research through various resources available at the University of Pennsylvania. The
University recognizes and takes responsibility for training the applicant in the area of
responsible conduct of research. The format for the education in the responsible
conduct of research will vary. Members of the training team will be available for formal
and informal problem-focused meetings. The applicant will meet face-to-face monthly
with Dr. Barbara Medoff-Cooper, to assure the understanding of informed consent,
have the opportunity to observe and debrief the deliberations of two different IRBs and
observe the peer review process. In addition, the applicant will have face-to-face
meetings with Dr. Medoff-Cooper regarding the conduct of research with families and
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vulnerable populations and to ensure protection of human subjects. The PI will
continue to participate in the University of Pennsylvania School of Nursing weekly
Research Colloquia, which is conducted though the Office of Nursing Research. In
addition, the PI will have access to monthly meetings in the Divisions of Family and
Community Health and Biobehavioral Research at the School of Nursing. Topics of
these hour-long sessions include, but are not limited to: conflict of interest (personal,
professional, and financial), policies regarding human subjects, mentor/mentee
responsibilities and relationships, collaborative research (including collaborations
with industry), peer review, data acquisition and laboratory tools, scientific integrity,
research misconduct (and policies for handling misconduct), responsible authorship
and publication, contemporary ethical issues in biomedical research, the scientist as
a responsible member of society, Federal Assurances, Internal Review Board (IRB)
basics, monitoring grant spending research with vulnerable populations, and
academic integrity.
The PI has completed on-line education on HIPAA certification and Protection
of Human Research Subjects- Biomedical, which satisfies the university’s requirement
for human subjects’ research training in the biomedical sciences. In addition, the PI has
completed the Subject Oriented Training in the School of Medicine. These modules
include information on informed consent, vulnerable populations, records research,
FDA regulated research, and conflicts of interest. In addition, the PI has completed
courses in clinical and research ethics. Issues of responsible conduct are included in
coursework of two research methods courses (quantitative and qualitative methods).
These courses are required of the applicant during doctoral education.
Protection of Human Subjects
The study will seek recruitment of a representative proportion of males and
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females indicative of the ethnic and racial distribution common to the PICU at CHOP.
All participants will be children who are at least 44 weeks post-conceptual age, but
have not yet had their 19th birthday, with a diagnosis of ALI and require mechanical
ventilation. The entire primary research team is trained and has extensive experience
in the care and clinical management of critically ill infants, children and adolescents. A
member of the research team will be available to communicate with enrolled families
and the PICU staff at all times to answer questions and explain procedures as
necessary. Weekend and off-hours coverage will be on a rotating basis.
Potential risks which would involve loss of lung volume during the IC
measurement, will be minimized by strict adherence to the study protocol. Should the
participant exhibit signs of distress during IC measurement, the assessment will be
aborted immediately. A critical care provider, RRT and critical care nurse will be
present at all times during IC measurement. The patient will be continuously monitored
by observation and electronic hemodynamic monitoring.
Potential benefit to the participants randomized to the study group include
precise prescription of energy needs to meet actual energy requirements with the
potential to increase ventilator free days, decrease loss of lean muscle mass, maintain
weight through critical illness, improve overall outcomes and decrease length of
hospitalization. These potential benefits hold promise for clinical implementation and
shift of clinical practice paradigms related to nutrition management for critically ill
children with ALI requiring mechanical ventilation. Participants randomized to the
control group will receive usual PICU care. The alternative to IC measurements to
determine energy needs is usual PICU care and families can opt to withdraw from the
protocol at any time, however all effort to maintain participation will be employed.
There are no financial or legal risks for participation in this study.
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Confidentiality
To protect against any risk to participant confidentiality, all printed data forms
will be coded with a unique anonymous identifier. This unique identifier will be stored
separately from files with personal health information (PHI) to maintain confidentiality.
As part of the of the consent process, participants will be made aware that
circumstances exist (regulatory or legal) where the research team will have to provide
subject information to others. Signed consent forms and other participant specific
forms and documents will be labeled with the participant’s name, these forms along
with a master list of participants will be secured separate from any information with PHI
and identification numbers in locked cabinets away from the PICU. Access will be
limited to those directly involved with this study. Databases will be maintained on a
secured, password-protected research quality network drive and maintained by the PI
in accordance with the standards of the School of Nursing at the University of
Pennsylvania and CHOP. The scheduled back up procedures in accordance with each
institution will be followed. Every effort to maintain participant information confidentiality
will be employed. All identifying data will be removed from files prior to electronic
transfer to the biostatistician. No individual subjects will be identifiable from written or
oral dissemination of the results of this study.
Data Safety Monitoring
There will be two levels of data and safety monitoring. The first level will be onsite, a study monitor (PI or other member of the study team) will verify data integrity,
compliance to the protocol and review source data and medical records, case report
forms and regulatory documents for completeness, accuracy and legibility.
Discrepancies will be discussed between the PI and study team as appropriate. The
study team will collect all data and perform initial data entry. A verification of data entry
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will then be performed by another member of the team. The second level of data and
safety monitoring will be the establishment of a Data and Safety Monitoring Board
(DSMB), which consists of individuals responsible for study oversight. The DSMB
members will be appointed by the PI with approval of the funding agency. The
Research Institute at CHOP and the University of Pennsylvania will be provided
names, and a summary of the background and expertise of the DSMB board members.
The DSMB members will consist of three faculty members independent of the research
team, two with expertise in pediatric critical care and one with expertise in
interpretation and analysis of energy expenditure measurements.
All DSMB members will be appointed for the five study years. They must disclose any
conflict of interest with the present study. The DSMB board will have a Chair and
Executive Secretary appointed. The DSMB will monitor study regulatory files,
enrollment tracking logs, informed consent forms, case report forms and overall study
protocol. The board will meet at least annually for these activities. The PI will be
responsible for scheduling the meetings and selecting items to be reviewed.
Inclusion of Women, Minorities, and Children
All participants in the study are children between post-conceptual age of 44
weeks and prior to their 19th birthday. The anticipated sample will be racially diverse as
CHOP serves a large local, regional, national and international community. Bi-weekly
meetings with the research team will include discussions surrounding recruitment and
retention of minority children. Concurrently, the PI and RA will participate in the
University of Pennsylvania, School of Nursing’s Culture and Diversity seminars. In the
over 3000 annual admissions in the PICU at CHOP in the preceding year, the diversity
distribution was 54% non-Hispanic White, 6.4% Hispanic, 28% African-American, 1.7%
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Asian/Pacific Islanders, < 1% Native American and 10% Other / Unknown / Decline to
Claim. Gender distribution was 58% to 42% male to female respectively.
Consortium Agreement
The Pediatric Intensive Care Unit (PICU) at The Children’s Hospital of
Philadelphia (CHOP) is a clinical, research facility were this randomized clinical trial
would be conducted.
Invertebrate Animals
There is no use of animals or collection of data from animals in this study.
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Chapter 4
Summary and Conclusions
There is abundant evidence associating growth failure and infants with
Congenital Heart Disease (CHD). This body of work further examines this relationship
through an investigation of growth velocity and energy expenditure in a sample of
infants with CHD following surgical intervention in early infancy. Although there is
debate clinically and in the literature on what constitutes growth failure in these infants,
the studies presented in this dissertation illustrate a negative statistical difference in
growth between infants with CHD and healthy infants. In addition, this data offers one
potential explanation – inadequate energy intake. Use of the newly developed World
Health Organization (WHO) child growth and growth velocity standards,1,2 make the
studies presented here novel in their approach to investigate growth in these infants.
Illustrating a difference in growth velocity compared to healthy infants and
demonstrating that energy expenditure in infants with CHD is not different from healthy
infants of the same age and gender, make this work is timely and important to the
clinical care of these infants. The following is a summation of the research findings and
their contribution to better understand growth failure in infants with CHD following
surgery in the neonatal period.
Specific Aims and Manuscript Review
Growth Monitoring
Growth Velocity
Growth velocity is the change over time in a given measure of physical
development. It can have high variability reflecting a naturally occurring pattern of
saltatory growth and catch-up or slow-down to account for a normal pattern of attained
growth reflected on standard growth charts.2 The first study of this dissertation, “Growth
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Velocity over the First Year of Life Following Neonatal Surgery for Congenital Heart
Disease” is a descriptive study describing the pattern of growth velocity for weight,
length and head circumference in a sample of infants with CHD following neonatal
surgery compared to healthy infants of similar age and gender. These data
demonstrate decreased growth velocity in infants with CHD compared to healthy
infants. Calculating and monitoring growth velocity growth is a more accurate way to
assess short and long-term changes in growth measures based on the time intervals
instead of a point in time.2,3 Using the WHO standards, which define growth based on
international child health standards, weight, length and head circumference, z-scores
and velocity z-scores were calculated. The standardized z-score measures clearly
exhibited a difference at 3-months of age, depicting lower z-scores and a decreased
rate of growth in infants with CHD. Despite the decreased rate of growth seen at 3
months of age, there was no difference in velocity z-scores for weight, length or head
circumference for the remaining time intervals, suggesting that the growth disparity of
early infancy is modifiable and that improved growth in infants with CHD is attainable.
These data provide a foundation on which to build a definition of growth failure in
infants with CHD. However, small sample size and missing data prevent development
of a definition based on this sample.
Although we measured growth velocity in 3-month intervals, the WHO growth
velocity standards allow for surveillance in weekly intervals in early infancy.2 The use of
these standards with close observation beginning at birth of attained growth and the
rate of change in growth parameters are a means for early identification of infants at
risk for poor growth. With early identification, early intervention is possible which can
prevent or minimize the degree of growth failure and decrease the potential for longterm morbidities that can result from poor growth in infancy.
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These data provide the platform for the design of strategies and interventions
aimed at increased caloric intake to assess if growth failure demonstrated in this study
by poor growth velocity is in fact modifiable. A program of feeding strategies that
supports an increase in energy intake may be the not so simple solution to this
persistent problem.4-8 Ongoing concentrated efforts in nutrition support aligned with
medical and nursing care may improve the rate of growth in infants with CHD to mirror
that of healthy infants. Further, this study may be the prologue of an intervention study
to develop and longitudinally test an intervention aimed at providing increased caloric
intake and monitoring infant response through feeding tolerance and attained growth
and growth velocity patterns. This may be a step at mitigating growth failure in infants
with CHD following neonatal surgery.
Energy Expenditure
The identification of differences in growth between infants with CHD and
healthy infants demonstrated in the study on growth velocity, presents a logical
progression to identify predictors of poor growth in these infants. Increased energy
expenditure related to cardiac physiology and the associated hemodynamic and
metabolic status is hypothesized to be a contributing factor in growth failure in infants
with CHD. This is the focus of the second study presented in chapter 2, “Resting
Energy Expenditure at 3-Months of Age in Infants Following Neonatal Surgery for
Congenital Heart Disease”. The primary aim of the study was to determine differences
in resting energy expenditure (REE), body composition and weight at 3-months of age
in infants with CHD compared to healthy infants. A secondary aim was to identify
predictors of REE in the same population.
Findings from this investigation reject the hypothesis that post surgical cardiac
physiology is the primary component driving energy expenditure. Further, no difference
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in REE was demonstrated between infants with CHD compared to healthy infants. In
fact, fat free mass (FFM) and infant age were the strong predictors of REE Kcal/day in
the study sample. Not only was cardiac physiology was not a primary causal factor, it
was not a major contributor to REE kcal in this study sample.
As expected, data from this study demonstrate FFM to be the primary predictor
of REE kcal. There was no difference in REE kcal between infants with CHD and
healthy infants, eliminating it, FFM, as contributing to poor growth in infants with CHD.
Instead, this study demonstrated % body fat to be lower in infants with cardiac disease,
which like accounts for their lower body weight in this study. This finding suggests
energy intake is inadequate in infants with CHD since FM and therefore % body fat is
directly related to caloric intake. Studies have shown poor nutrient intake during
hospitalization, poor weight gain at hospital discharge, and reports of inconsistent
feeding tolerance once home.4,9-11 The decreased accretion of fat demonstrated in this
study at 3-months of age suggests that poor weight gain continues post hospital
discharge. This was an interesting finding as it further supports the hypothesis that
consistent energy and nutrient intake are a challenge for infants with CHD and may be
the basis for poor weight gain and subsequent growth failure. It was striking that the
infants with CHD showed an increased REE difference of only 8 kcal/day compared to
healthy infants, however, kg weight and WHO weight z-scores were significantly
different between the groups. This is most likely explained by the significantly lower %
body fat these infants exhibited. Clinically, these findings suggest poor attained weight
at 3-months of age is related to inadequate caloric intake and the inability of these
infants to attain and sustain a positive energy balance that is necessary for fat and lean
body mass accretion.
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It is important to note that these findings did not indicate cardiac physiology to
be a predictor for REE kcal in infants with CHD. This dispels the commonly held view
that cardiac disease is the basis for growth failure these infants often exhibit. In
addition, these findings support that idea that with focused concentrated nutrition
support along with medical and nursing care, growth failure seen in early infancy is
reversible and it is possible for these infant to attain their genetic growth potential.
Similar to the study on growth velocity, these findings present a platform for a program
of research investigating the unique feeding, energy and nutrient intake needs of
infants with CHD. Further, this study supports the idea of incremental measurements
of body composition in these infants to assess their nutrition status by the amount of
lean body mass compared to body fat mass, which can direct prescriptions for energy
and nutrient intake.
These studies examined questions focused on growth and nutrition status in
infants with cardiac disease following neonatal surgery. They present important data
that can be used as a platform for further inquiry and clinical practice. The introduction
of the WHO growth and growth velocity standards for infants and children, provide
excellent tools to further the inquiry surrounding growth and nutrition in clinical practice
and research endeavors.12 The WHO standards have indices for weight, length, head
circumference and growth velocity that have proven successful in the studies
presented to evaluate growth. 1,2 The child growth and growth velocity standards can
be useful for designing protocols and to identify specific parameters that can be used
to define growth failure in infants with chronic illness such as CHD, however the
studies presented suggest poor growth seen in early infancy is reversible and normal
growth patterns for infants with CHD attainable.
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These investigations of growth and growth failure in infants with CHD are
important not only for somatic growth and its association with child health, but also for
the sequela that is associated with poor growth. Numerous associations exist between
cognitive, neurodevelopmental and neurobehavioral deficits in children who have
experienced poor growth in infancy. In both the general pediatric literature and the
pediatric cardiac literature, poor growth in infancy has the potential to have residual
effects well into childhood. The work of this dissertation has elucidated information that
potentially can intervene in growth failure in early infant and may in turn thwart the
associated untoward cognitive and neurologic outcomes seen in childhood.
Study Limitations
The limitations presented here are relevant to both studies presented in
Chapter 2. These include both studies are single center cohorts. This limits the
generalizability of the findings but lays the groundwork for replication of each of the
study protocols as larger clinical trials to determine reproducibility and generalizability
of the study results. The study setting, The Children’s Hospital of Philadelphia (CHOP),
may have a higher acuity of cardiac disease than that seen and treated in other
centers. Therefore, study findings may not be applicable in all pediatric cardiac
settings. Recruitment for both studies occurred approximately 8 years prior, with the
changes in surgical approach and technology these study findings may have a
decreased impact in the research community. Assessment of dietary intake was
attempted but the Neither investigation had reliable dietary intake data available for
analysis, which would have strengthened the results. Birth data was extracted from the
transport record that accompanied the infant to CHOP leaving question to its reliability,
and reducing any inference that can be made regarding growth and growth velocity
between birth and 3-months of age. Information learned from the 3-month data in both
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studies, indicate the time between hospital discharge and 3 months of age in infants
with CHD may be crucial to better understanding growth issues in these infants. There
may be bias in that the families that enrolled and participated were motivated and
actively participated in the rigorous research protocol. Data is not available to address
familial educational or socioeconomic status and whether this reflects or impacts study
enrollment. Lastly, the study sample may not completely represent families with infants
that had the most challenging hospital course and were therefore not willing to consent
to study participation. These issues singularly or in combination, they may influence
study results.
NIH Director’s Early Independence Award Application
To move the science forward and to ‘translate’ the knowledge and skills
obtained over the course of this dissertation work, a grant proposal was prepared and
submitted to the National Institutes of Health (NIH) as a candidate for an Early
independent Investigator award. This proposal entitled: “The Use of Indirect
Calorimetry (IC) to Measure Energy Needs in Mechanically Ventilated Children with
Acute Lung Injury”, represents a modified approach to translational research,
addressing the adoption of best practice.13 As part of this dissertation, this proposal
serves to demonstrate the importance of translation of knowledge to support the idea
of best practice in the care of children. Through knowledge gained from the testing and
analysis of energy expenditure in postsurgical infants with complex CHD, this
application, designed as a clinical trial proposes to measure energy expenditure in
critically ill children requiring mechanical ventilation. The goal of this proposed trial was
to assess energy needs through the use of indirect calorimetry in children with acute
lung injury requiring mechanical ventilation. The specific aim of the proposed study is
to measure energy expenditure using indirect calorimetry to assess and prescribe
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caloric intake specific to energy needs as compared to standard current practice of
prescribing energy intake from the use of prediction equation calculations. Research
has shown that prediction equations often under or overestimate energy requirements,
which can threaten clinical outcomes14-16. In this dissertation work, the investigation of
energy expenditure in infants with cardiac disease demonstrated the inaccuracy of
prediction equations to estimate energy needs when compared to measured energy
expenditure. This proposal exemplifies the need to further study measurement of
energy expenditure and its impact on participant outcomes versus the use of
equations.
Many of the current therapies and much of our understanding of disease
progression and appropriate treatment for children are derived from adult science.
This practice can be challenging as knowledge is gained about differences between
adults and children in their presentation and response to illness and treatment.
This proposal exemplifies the importance of conducting research specific to infants and
children to better understand pediatric response to illness, treat the unique needs of
the pediatric population and improve care delivery and overall outcomes. This is
particularly true in regards to energy needs, which can influence response to illness
and has long-reaching consequences for optimal health.
Future Research
The current body of work can move forward in two directions. The first would be
to replicate the research presented to a larger sample and follow the cohort for a longer
period. This would allow serial monitoring of growth measures, and the collection of
more data points to better examine and understand growth and growth velocity in both
healthy infants and those with CHD. Data on nutrient intake during the study period
will also improve understanding of growth and growth failure and can provide for
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recommendations for caloric and nutrient intake, improve prescriptions for energy
needs based on actual energy intake and expenditure, and provide for a better
assessment of growth measures. This will better define growth, growth velocity and
growth failure in infants with complex CHD relating their nutrient intake, nutrition status
and growth parameters. This trajectory of research will establish a foundation to
develop nutrition support programs for infants are at risk for growth failure. Initiating
nutrition support programs can establish another tier of continued research to monitor
program success with incremental assessments of growth, growth velocity, body
composition and energy expenditure.
A second direction for future research would parallel the ideas outlined in the
grant proposal. There is much to understand the nutritional needs of infants and young
children during critical illness. With ongoing evidence that the prediction equations are
inadequate, it follows that a more accurate method is necessary to address energy
needs and prescription of appropriate energy and nutrient intake during critical illness.
Measurement of caloric needs with prescription and delivery specific to those needs
can be an adjunct to care in critically ill children and has potential to improve outcomes.
In pediatric critical care, appropriate provision of energy and nutrients remains a
challenge, both researchers and clinicians acknowledge meeting nutrition needs to be
an important aspect of care during and immediately following hospitalization. Accurate
nutrition prescriptions based on measured energy expenditure can decrease
complications associated with inadequate nutrient intake in critical illness, i.e. weight
loss, alteration in body composition, and length of hospitalization.
Based on work throughout this dissertation, the conceptual model introduced at
the outset can be modified. This work suggests energy balance is modifiable, and that
modification can effect growth in infants with cardiac disease who have undergone
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surgical intervention in the neonatal period. The possibilities for future nutrition and
growth research born from this dissertation work abound and provide an exciting
outlook for the direction of investigations in the care of infants and young children.
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Figure 1 Modified Conceptual Model
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Modified schematic of the concept of potential influences on growth in infants with CHD
following surgical intervention in the neonatal period
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CLOSING
Commencement May 16, 2011
PhD Student Speaker Address:
University of Pennsylvania,
School of Nursing
Kimmel Center, Philadelphia, PA
LOOK AT US NOW
Good Afternoon. To Dean Meleis, Ms Greco, Dr Savard, Dr Shalala, esteemed faculty,
honored guests, fellow graduates, family and friends:
LOOK AT US NOW
LOOK AT US. To my graduating colleagues, you remember year “1”. We were all
sitting in Dr Julie Fairman’s class on the “Philosophy of Science in Nursing”. You
remember – we were told that we were about to have our brains unpacked, scrambled
and then by graduation – sometime in the future, we would re-packed our brains with
some of the same but also with enhanced and new knowledge. Who knew we would
learn the language of post-modernism, empiricism, feminism, relativism and the
like…Well – LOOK AT US NOW, the repacking has been a journey, but much easier
than we thought…
LOOK AT US NOW. Remember - “Concept Analysis” – some of us had to stretch,
because to conceptualize we thought, was well beyond our reach, we provided care, it
was tangible, not a concept… but, concept building, it was a part of the unpacking and
the scrambling; we had yet to reach the repacking stage, so we needed a concept, a
model on how to do it...
LOOK AT US NOW. We have poked proteins; examined phthalates; uncovered
properties of skin elasticity; cared for the elderly; scrutinized kidney disease; held
heart to heart talks with immigrants; used history to explore our nursing identity;
examined symptom clusters in cancer; followed mothers and children with HIV;
wacked on a few mice; probed into psychiatric assessment; thought about sleep –
while we were losing it; investigated the impact of vitamin D in diabetes; examined
school performance in ex- preemies and studied the expenditure of energy in infants
with congenital heart disease… In essence, we have repacked our brains and in doing
so, we have added to the knowledge of nursing science, we are becoming
epistemologists…LOOK AT US NOW!
LOOK AT US – now we initiate and we lead the conversations on: “the literature tells
us”, “the research is lacking” and “recent data suggests”…that’s us talking and us
saying those words! LOOK AT US NOW!
LOOK AT US – while we repack of our brains, we also pack tools…tools to pioneer
new thought processes, tools to formulate new questions, tools to be a new wave of
nurse scientist...tools with which we will build new knowledge – epistemologically
speaking…
140

LOOK AT US NOW… to everyone here, go-ahead look around - remember these
names and these faces for we are a generation of nurse scientists who are multitalented, and the world has just become our playground.
So, everyone, take a look…look at this class of PhD graduates of the University of
Pennsylvania, School of Nursing for 2011… But don’t blink or look away, because once
you do, you will miss the continuation of the repacking, you will miss epistemology in
the making… because along the way, we found out, the unpacking and repacking – it
doesn’t end, it just changes. We will forever unpack and repack – it is through that
process that tools for continued growth and advancement develop, it is through that
process that innovations and innovators – my graduating colleagues, are discovered…
LOOK AT US NOW…I am humbled, proud and so very honored to have been
nominated by you, my classmates to represent the 2011 PhD class…We walk out as
newly graduated nurse scientists who have the ability to teach, to practice, to question
and disseminate findings (please don’t forget to publish!)…and through the process we
will continue to add to the knowledge of the science of nursing
So, Dean Melesis, Ms Greco, Dr Savard, Dr Shalala, esteemed faculty, honored guests
and friends – keep your eyes on us, WE ARE A FORCE!
LOOK AT US NOW!!!
Thank you.

The Acquisition of Knowledge
"The acquisition of knowledge is always of use to the intellect, because it may thus
drive out useless things and retain the good. For nothing can be loved or hated unless
it is first known."

Leonardo da Vinci
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